cephalosporin c has been researched along with hr 810 in 340 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 59 (17.35) | 18.7374 |
| 1990's | 202 (59.41) | 18.2507 |
| 2000's | 55 (16.18) | 29.6817 |
| 2010's | 21 (6.18) | 24.3611 |
| 2020's | 3 (0.88) | 2.80 |
| Authors | Studies |
|---|---|
| Girlich, D; Leclercq, R; Naas, T; Nordmann, P | 1 |
| Anderson, KC; Kellogg, GE; Sarkar, A | 1 |
| Amalfitano, G; Canepari, P; Fontana, R; Ligozzi, M; Piacentini, E | 1 |
| Bale, MJ; Erwin, ME; Gerlach, EH; Jones, RN; Koontz, FP; Murray, PR; Washington, JA | 1 |
| Isert, D; Klesel, N; Limbert, M; Markus, A; Schrinner, E; Seibert, G; Winkler, I | 1 |
| Guy, JM; Legg, EF | 1 |
| Griggs, DJ; Piddock, LJ; Traynor, EA | 1 |
| Allard, S; Auger, F; Bisson, C; Daviau, N; Drapeau, C; LeBel, M; Paradis, D; Vallée, F | 1 |
| Imada, A; Kita, Y; Yamazaki, T | 1 |
| Hiruma, R; Katsu, K; Watanabe, N | 1 |
| Akieda, Y; Imamura, N; Katagiri, K; Nakayama, I; Nitta, Y; Ohishi, M; Takase, K; Yamaji, E | 1 |
| Miyake, A; Nishimura, T; Yoshimura, Y | 1 |
| Isert, D; Klesel, N; Limbert, M; Markus, A; Schrinner, E; Seibert, G | 3 |
| Chen, BL; Hubbard, JW; Lassman, HB; Puri, SK | 1 |
| Budny, JL; Divan, K; Lassman, HB; Mitchell, P; Nix, DE; Schentag, JJ; Velasquez, N; Wilton, JH | 1 |
| Chavanet, P; Dematons, C; Kazmierczak, A; Lenfant, B; Pechinot, A; Portier, H; Wolff, M | 1 |
| Badian, M; Drees, B; Eckert, HG; Luus, HG; Meyer, BH; Muller, FO; Röthig, HJ | 1 |
| Doerr, HW; Hellwich, S; Schäfer, V; Seibert, G; Shah, PM; Ziemen, M | 1 |
| Donaubauer, HH; Mayer, D | 1 |
| Krauskopf, S; Schäfer, V; Shah, PM; Ziemen, M | 1 |
| Badian, M; Knothe, H; Sammann, A; Schäfer, V; Shah, PM | 1 |
| Carbon, C | 1 |
| Hendry, IR; Johnson, VA; Kearns, GL; Wells, TG | 1 |
| Drees, B; Lameire, N; Lehr, K; Malerczyk, V; Rosenkranz, B | 1 |
| Iwahi, T; Nakao, M; Noji, Y; Yamazaki, T | 1 |
| Bauernfeind, A; Eberlein, E; Jungwirth, R; Schweighart, S | 1 |
| Andrews, JM; Wise, R | 1 |
| Filipiak, C; Grüneberg, RN; Kulkarni, S; Samuell, CT; Wilson, AP | 1 |
| Andrews, JM; Ashby, JP; Baldwin, DR; Honeybourne, D; Maxwell, SR; Wise, R | 1 |
| Piddock, LJ; Traynor, EA | 1 |
| Davey, PG; Finch, RG; Moreland, TA; Pithie, A; Smith, G; Wilcox, MH | 1 |
| Ogata, Y; Saruta, T; Suzuki, H | 1 |
| Inoue, M; Inouye, S; Komiya, I; Kondo, S; Mitsuhashi, S; Ogino, H; Okamoto, R; Tamura, A; Yoshida, T | 1 |
| Kanazawa, Y; Kuramata, T; Murata, A; Ogino, A; Saito, H; Sekine, H | 1 |
| Boice-Sowek, J; Dougherty, TJ; Kessler, RE; Pucci, MJ | 1 |
| Haruta, T; Kobayashi, Y; Kuroki, S; Naramura, M; Nigami, H; Okura, K; Yamakawa, M; Yoshida, N | 1 |
| Barrett, MS; Briggs, BM; Erwin, ME; Johnson, DM; Jones, RN | 1 |
| Hirama, Y; Matsumoto, K; Nagao, K; Nakanishi, Y; Nakazawa, S; Narita, A; Niino, K; Sato, H; Suzuki, H | 1 |
| Andou, H; Kito, O; Kuno, K; Ogawa, A; Takeuchi, H; Takimoto, Y; Tomita, K | 1 |
| Higashi, H; Ito, S; Mayumi, M; Mikawa, H | 1 |
| Aoki, S; Nishimura, T; Tabuki, K; Takagi, M | 1 |
| Kuroda, Y; Matsuoka, S; Takahashi, Y | 1 |
| Kouzan, H; Murakawa, K; Nishimori, M; Ohara, K; Okamoto, T; Sekiguchi, T; Shiino, Y | 1 |
| Furukawa, S; Okada, T | 1 |
| Miyazoe, H; Nagano, K; Nakayama, N; Tuji, Y | 1 |
| Iwai, N; Miyazu, M; Nakamura, H; Taneda, Y; Watanabe, Y | 1 |
| Aso, Y; Hirose, T; Kawada, Y; Kumamoto, Y; Machida, T; Naide, Y; Orikasa, S; Oshi, M; Suzuki, K; Tsuchida, S | 1 |
| Hosoi, Y; Ono, K; Saiko, Y; Saito, I; Tahara, T; Yokozawa, M | 1 |
| Engelbart, K; Horstmann, G | 1 |
| Bellido, F; Hancock, RE; Pechère, JC | 1 |
| Jafari, HS; McCracken, GH; Ramilo, O; Sáez-Llorens, X; Shelton, SL | 1 |
| Haruta, T; Kobayashi, Y; Kuroki, S; Okura, K | 1 |
| Akita, H; Ikeda, M; Isohata, E; Iwata, S; Kin, Y; Kusumoto, Y; Oikawa, T; Sato, Y; Sunakawa, K; Yokota, T | 1 |
| Abe, T; Fujii, R; Hirama, Y; Matsumoto, K; Meguro, H; Nakazawa, S; Narita, A; Sato, H; Tajima, T | 1 |
| Abe, T; Fujii, R; Meguro, H; Tajima, T | 1 |
| Akita, H; Iwata, S; Sato, Y; Sunakawa, K | 1 |
| Kawamura, K; Sakaguchi, N; Seo, K; Sugita, M; Toyonaga, Y; Yamori, K | 1 |
| Ihara, T; Ito, M; Kamiya, H; Sakurai, M | 1 |
| Cho, S; Higashino, H; Hirabayashi, Y; Kawasaki, H; Kino, M; Kobayashi, Y; Kohdera, U; Nakamura, M; Suzukawa, J; Woo, M | 1 |
| Kida, K; Matsuda, H; Morimoto, T; Murase, M | 1 |
| Fujieda, M; Kido, S; Maeda, A; Maeda, H; Morita, H; Ohishi, N; Shimazaki, Y; Takechi, T; Takeda, K; Wakiguchi, H | 1 |
| Hino, J; Hiraga, Y; Kawanishi, M; Matsushima, T; Ohmichi, M; Okimoto, N; Soejima, R; Sumi, M; Tsukiyama, K; Yagi, S | 1 |
| Hino, J; Kawakami, Y; Okimoto, N; Saito, A; Soejima, R; Sumi, M; Takaoka, K; Terai, T; Yamaguchi, E; Yoshikawa, T | 1 |
| Abe, S; Inazu, M; Kobayashi, T; Omosu, M; Oshima, K; Satoh, R; Wada, N | 1 |
| Akaike, M; Inazu, M; Kobayashi, T; Ohno, H; Omosu, M; Takayama, K | 1 |
| Deki, T; Higo, S; Kokuba, S; Kumagai, Y; Ohtani, T; Sakamaki, Y; Uchiyama, T | 1 |
| Inoue, S; Kobayashi, T; Morioka, H; Omosu, M; Satoh, R; Yoshida, Y | 1 |
| Goto, K; Inazu, M; Kobayashi, T; Morioka, H; Omosu, M; Satoh, R; Tanaka, T; Yajima, R | 1 |
| Deki, T; Horiuchi, K; Marutani, K; Masuda, K; Matsuoka, A; Matsuzawa, T; Nakagawa, T; Niki, R; Ohishi, T; Ohtani, T | 1 |
| Igarashi, S; Kumagai, Y; Sugiyama, O; Tanaka, K; Toya, M; Tsuji, K; Watanabe, K; Watanabe, S | 3 |
| Donaubauer, HH; Engelbart, K; Mayer, D | 1 |
| Baltch, AL; Ritz, WJ; Smith, RP; Valdes, JM | 1 |
| Ansorg, R; Primavesi, CA; von Recklinghausen, G | 1 |
| Spencer, RC; Wheat, PF | 1 |
| Baltch, AL; Hammer, MC; Ritz, WJ; Smith, RP; Valdes, JM | 1 |
| Baltch, AL; Franke, M; Michelsen, P; Ritz, WJ; Singh, J; Smith, RP; Valdes, JM; Williams, S | 1 |
| Hubrechts, JM; Nulens, E; Nyssen, HJ; Roebben, E; Vanhoof, R | 1 |
| Arai, S; Hayashi, S; Kobayashi, S | 1 |
| Barry, AL; Fuchs, PC; Jones, RN | 1 |
| Mitsuhashi, S; Yoshida, M | 1 |
| Boothman, C; King, A; Phillips, I | 1 |
| Fujimoto, T; Inoue, M; Mitsuhashi, S; Watanabe, M | 1 |
| Asano, T; Chikaraishi, Y; Kuriki, T; Saito, K; Sano, A; Shirotsuka, M; Sugioka, T; Suzuki, E | 1 |
| Cojocel, C | 1 |
| Andrews, JM; Arkell, DG; Saxby, MF; Wise, R | 1 |
| de Mier, C; Fernández, A; Herran, I; Marcenac, FM | 1 |
| Buccini, F; Cherubin, CE; Eng, RH; Harris, R; Smith, SM | 1 |
| Ashby, JP; Donovan, IA; Kavi, J; Wise, R | 1 |
| Hiraoka, M; Mitsuhashi, S; Satake, S | 1 |
| Fuchs, PC; Jones, RN | 1 |
| Bakhtiar, M; Selwyn, S | 1 |
| Chavanet, P; Kazmierczak, A; Pechinot, A; Portier, H; Waldner-Combernoux, A | 1 |
| Inoue, M; Mitsuhashi, S; Mitsukude, M | 1 |
| Bartmann, K; Tarbuc, R | 1 |
| Chandrasekar, PH; Levine, DP; Price, S | 1 |
| Houben, AW; Stobberingh, EE | 1 |
| Cantey, JR; Raizes, EG | 1 |
| Bryskier, A; Croize, J; Le Noc, D; Le Noc, P | 1 |
| Blumbach, J; Duerckheimer, W; Fehlhaber, HW; Fleischmann, K; Kirrstetter, R; Lattrell, R; Mencke, B; Scheunemann, KH; Schrinner, E; Schwab, W | 1 |
| Gargalianos, P; Livermore, DM; Oppenheim, BA; Skepastianos, P; Williams, RJ | 1 |
| Chin, NX; Neu, HC; Novelli, A | 1 |
| Butzler, JP; Coignau, H; De Mol, P; Ghysels, G; Goossens, H; Grados, O; Innocent, H; Levy, J | 1 |
| Badian, M; Collins, JD; Dixon, GT; Eckert, HG; Malerczyk, V; Verho, M | 1 |
| Jacobs, RF; Kearns, GL; Turley, CP | 1 |
| Blumbach, J; Duerckheimer, W; Fleischmann, K; Kirrstetter, R; Klesel, N; Lattrell, R; Mencke, B; Scheunemann, KH; Schwab, W; Seliger, H | 1 |
| Duerckheimer, W; Lattrell, R; Limbert, M | 1 |
| Arai, S; Hayashi, S; Kobayashi, S; Sakaguchi, T | 1 |
| Alestig, K; Burman, LA; Dotevall, L; Eriksson, M; Larsson, P; Lundholm, R; Norrby, SR; Settergren, B | 1 |
| Aldridge, KE; Barry, AL; Fuchs, PC; Jones, RN | 1 |
| Andrews, JM; Ashby, JP; Hillman, G; Kavi, J; Wise, R | 1 |
| Alvarez, ME; Bodey, GP; Hsu, KC; Rolston, KV | 1 |
| Appelbaum, PC; Sollenberger, L; Spangler, SK | 1 |
| Arai, S; Fujimoto, K; Hayashi, S; Kobayashi, S | 2 |
| Dürckheimer, W; Kirrstetter, R; Lattrell, R; Limbert, M; Seibert, G | 1 |
| Isert, D; Klesel, N; Limbert, M; Schrinner, E; Seibert, G; Winkler, I | 1 |
| Bryskier, A; Le Noc, D; Le Noc, P | 1 |
| Grötsch, H; Hajdu, P | 1 |
| Borobio, V; Garcia-Iglesias, MC; Pascual, A; Perea, EJ | 1 |
| Murray, PR; Niles, AC | 1 |
| Barry, AL; Jones, RN; Thornsberry, C | 2 |
| Alvarez, ME; Bodey, GP; Ho, DH; Hoy, JF; LeBlanc, B; Rolston, K | 1 |
| Hackbarth, CJ; Rusnak, MG; Sande, MA; Scott, KG; Täuber, MG | 1 |
| Clarke, AM; Wright, JM; Zemcov, SJ | 1 |
| Peddie, BA | 1 |
| Andrews, JM; Cross, C; Piddock, LJ; Wise, R | 1 |
| Cullmann, W; Dick, W | 1 |
| Bawdon, RE; Brater, DC; Lu, YS | 1 |
| Barry, AL; Fuchs, PC; Jones, RN; Thornsberry, C | 1 |
| Bauernfeind, A | 2 |
| Citron, DM; Goldstein, EJ | 1 |
| Bryskier, A; Chantot, JF | 2 |
| Gerlach, EH; Jones, RN | 1 |
| Braveny, I; Machka, K | 1 |
| Cullmann, W; Opferkuch, W; Stieglitz, M | 1 |
| Blumbach, J; Dürckheimer, W; Fleischmann, K; Klesel, N; Lattrell, R; Limbert, M; Schrinner, E; Seeger, K; Seibert, G; Winkler, I | 1 |
| Klesel, N; Limbert, M; Seibert, G | 1 |
| Ayers, L; Barry, AL; Brown, S; Daniel, J; Fuchs, PC; Gavan, TL; Gerlach, EH; Jones, RN; Matsen, JM; Thornsberry, C | 1 |
| Bertram, MA; Bruckner, DA; Young, LS | 1 |
| Tolxdorff-Neutzling, RM; Wiedemann, B | 1 |
| Cony Makhoul, P; Darmaillac, V; Fourche, J; Maugein, J; Perrier, F | 1 |
| Baquero, F; Cantón, R; García de Lomas, J; Gimeno, C; Liñares, J; Martínez-Beltrán, J; Tubau, F | 1 |
| Chanal, M; Derlot, E; Duval, J; Goldstein, F; Soussy, CJ | 1 |
| Harauchi, T; Hirata, M; Itoh, F; Mizushima, Y; Sato, K | 1 |
| Hof, H | 1 |
| Bouvier d'Yvoire, M; Breilh, D; Closse, C; Grellet, J; Leng, JJ; Saux, MC | 1 |
| Brandt, CM; Rouse, MS; Steckelberg, JM; Tallan, BM; Wilson, WR | 1 |
| Jones, RN; Sader, HS | 1 |
| Baltch, AL; Ritz, W; Smith, RP | 1 |
| Carbon, C; Fantin, B; Farinotti, R; Thabaut, A | 1 |
| Kobayashi, H | 1 |
| Hosoi, Y; Saiko, Y; Saito, I; Tahara, T | 1 |
| Etienne, JP; Hagège, H; Laurent-Puig, P; Singlas, E; Taburet, AM; Taugourdeau, MC | 1 |
| Deguchi, K; Kaburagi, T; Miyake, S; Nagai, H; Satoh, K; Shishido, H | 1 |
| Low, DE; Scriver, SR; Toye, BW | 1 |
| Deguchi, K; Fukayama, S; Fukumoto, T; Ishihara, R; Koguchi, M; Nakane, Y; Oda, S; Suzuki, Y; Tanaka, S; Yokota, N | 1 |
| Blanco, MT; Gómez-García, AC; Hurtado, C; Morán, FJ; Pérez-Giraldo, C; Puente, LF | 1 |
| Ehrett, S; Friedland, IR; Hickey, S; McCracken, GH; Olsen, K; Paris, M | 1 |
| Lameire, N; Lehr, KH; Malerczyk, V; Ringoir, S; Rosenkranz, B; Veys, N | 1 |
| Hayashi, T; Kawahara, S; Kosaka, Y; Yoshimura, H | 1 |
| Nix, DE; Strenkoski, LC | 1 |
| Katsu, K; Watanabe, N | 1 |
| Labs, R; Reeves, A; Rubinstein, E | 1 |
| Chen, HY; Livermore, DM | 1 |
| Verbist, L | 1 |
| Spencer, RC | 1 |
| Craig, WA | 1 |
| Norrby, SR | 1 |
| Geddes, AM; Norrby, SR | 1 |
| Cheng, AF; Fung, KS; Lam, AW; Ling, TK; Wise, R | 1 |
| Coulthard, M; Ehrett, S; Friedland, IR; Jafari, H; McCracken, GH; Olsen, K; Paris, M; Rinderknecht, S; Saxen, H | 1 |
| Hori, S; Kanemitsu, K; Shimada, J | 1 |
| Hatano, K; Higashi, Y; Kamimura, T; Kuno, K; Matsumoto, F; Matsumoto, Y; Mine, Y; Sakamoto, H; Tawara, S; Watanabe, Y | 1 |
| Kamimura, T; Kawabata, K; Ohki, H; Okuda, S; Sakane, K | 1 |
| Bywater, MJ; Holt, HA; Reeves, DS | 1 |
| Allen, LV; Prince, SJ; Stiles, ML; Sylvestri, MF | 1 |
| Bingen, E; Doit, C; Fitoussi, F; Geslin, P; Kazmierczack, A; Pechinot, A; Sandin, A | 1 |
| Barry, AL; Brown, SD; Novick, WJ | 1 |
| Barson, WJ; Nahata, MC; Puri, SK | 1 |
| Kim, IC; Kim, MY; Kim, YZ; Kwak, JH; Oh, JI; Song, HK | 1 |
| Laws, A; Page, M | 1 |
| Wise, R | 1 |
| Modai, J | 1 |
| Giamarellou, H | 1 |
| Shah, PM | 1 |
| Elkhaïli, H; Jehl, F; Kamili, N; Linger, L; Monteil, H; Pompei, D | 1 |
| Cavalier, A; Elkhaïli, H; Jehl, F; Kaltenbach, G; Levêque, D; Monteil, H; Peter, JD; Salmon, J; Salmon, Y | 1 |
| Iakovlev, SV; Iakovlev, VP | 1 |
| Hamada, Y; Kuroda, E; Munemoto, S; Nakada, M; Soma, M | 1 |
| Deguchi, K; Fukayama, S; Ishihara, R; Koguchi, M; Oda, S; Suzuki, Y | 1 |
| Hasegawa, H; Kanai, A; Otoguro, K; Shimizu, K | 1 |
| Hoppe, JE; Rahimi-Galougahi, E; Seibert, G | 1 |
| Jacolot, A; Louchahi, K; Mimoz, O; Padoin, C; Petitjean, O; Quillard, J; Samii, K; Tod, M | 1 |
| Appelbaum, PC; Bajaksouzian, S; Jacobs, MR; Visalli, MA | 1 |
| Constantoulaki, S; Dimitropoulos, N; Niha, M; Paniara, O; Pierros, N; Platsouka, E | 1 |
| Gutiérrez Fernández, J; Hoyos López, A; Piédrola Angulo, G | 1 |
| Gutiérrez, J; Hoyos, A; Piédrola, G | 1 |
| Hara, H; Higuchi, T; Imagawa, A; Murahashi, M; Wakayama, Y | 1 |
| Atteneder, M; Breyer, S; Burgmann, H; Elmenyawi, I; Georgopoulos, A; Graninger, W; Hollenstein, U; Hörl, WH; Mayer, G; Putz, D; Rosenkranz, AR; Schmaldienst, S; Thalhammer, F | 1 |
| Bergeret, M; Raymond, J; Vedel, G | 2 |
| Hamazaki, H; Hara, H; Hasegawa, H; Hiraoka, A; Horiuchi, A; Hukuhara, S; Inoue, N; Kageyama, T; Kakishita, E; Kanamaru, A; Kanayama, Y; Kawagoe, H; Kitani, T; Masaoka, T; Nagai, K; Nasu, K; Sugiyama, H; Takahashi, T; Takatsuka, H; Tatsumi, N; Teshima, H; Tukaguchi, M; Uchino, H | 1 |
| Archbold, P; Ferguson, WP; Kerr, JR | 1 |
| Allende, H; Almirante, B; Capdevila, JA; Crespo, E; Gavaldà, J; Laguarda, M; Otero, J; Pahissa, A; Pigrau, C; Ruiz, I | 1 |
| Härtl, A; Mrestani, Y; Neubert, R; Schiewe, J | 1 |
| Agneter, E; Burgdorff, T; Eichler, HG; Georgopoulos, A; Haag, O; Jansen, B; Müller, M; Pehamberger, H; Stanek, G; Weninger, W | 1 |
| Apul'tsina, ID; Avdeev, SN; Chuchalin, AG; Gugutsidze, EN; Kuchkina, NV; Sokolov, AS | 1 |
| Belousov, IuB; Gudkin, AB; Izotova, GN | 1 |
| Il'ina, NI; Shul'zhenko, AE | 1 |
| Alekseev, AA; Blatun, LA; Iakovlev, VP; Izotova, GN; Krutikov, MG; Puchkova, LS; Svetukhin, AM | 1 |
| Derevianko, II; Khodyreva, LA; Kondrat'eva, EM; Kotliarova, GA; Siniukhin, VN | 1 |
| Dvoretskiĭ, LI; Eremina, LV; Iakovlev, SV; Shakhova, TV | 1 |
| Navashin, PS; Navashin, SM | 1 |
| Iakovlev, VP; Levshin, IB | 1 |
| Makarov, AN; Makarova, RA; Rezvan, SP; Sidorenko, SV | 1 |
| Kabutomori, O; Koh, T; Nishiyama, M; Yanagihara, T | 1 |
| Lamb, HM; Wiseman, LR | 1 |
| Ashhurst-Smith, C; Norton, R; Seymour-Murray, J | 1 |
| Elkhaïli, H; Jehl, F; Levêque, D; Linger, L; Monteil, H; Niedergang, S; Peter, JD; Pompei, D; Salmon, J; Salmon, Y; Thierry, RC | 1 |
| Canis, F; Cavallo, JD; Husson, MO | 1 |
| Ho, SW; Hsueh, PR; Luh, KT; Teng, LJ; Yang, PC | 1 |
| Gazouli, M; Giakkoupi, P; Katrahoura, A; Legakis, NJ; Paniara, O; Prinarakis, E; Tzelepi, E; Tzouvelekis, LS | 1 |
| Wolff, M | 1 |
| Friedland, IR; Lehr, KH; Lenfant, B; Sultan, E | 1 |
| Derendorf, H; Eichler, HG; Georgopoulos, A; Kovar, A; Müller, M; Rohde, B | 1 |
| Kolár, M | 1 |
| Appelbaum, PC; Jacobs, MR; Visalli, MA | 1 |
| Auckenthaler, R; Bille, J; Breer, C; Frei, R; Liassine, N; Wüst, J | 1 |
| Verbist, L; Verhaegen, J | 1 |
| Emmerechts, K; Lauwers, S; Piérard, D | 1 |
| Escande, MC; Herbrecht, R | 1 |
| Garau, J | 1 |
| Van haute, I; Verschraegen, G | 1 |
| Hoogkamp-Korstanje, JA; Meis, JF; Verduyn Lunel, F | 1 |
| Benn, R; Fernandes, C; Morris, A; Pritchard, R | 1 |
| Horiba, M; Kumazawa, J; Matsumoto, T; Naide, Y | 1 |
| Geddes, AM; Norrby, SR; Shah, PM | 2 |
| Fremaux, A; Geslin, P; Sissia, G; Spicq, C | 1 |
| Bessho, M; Endo, K; Fukuda, M; Hirashima, K; Kawai, N; Kobayashi, Y; Tominaga, K | 1 |
| Au, C; Chan, CY; Cheng, AF; Cheung, SW; Ip, M | 1 |
| Fruchart, A; Husson, MO; Izard, D | 1 |
| Davies, JG; Kingswood, C; Olliff, CJ; Phillips, GJ; Street, M | 1 |
| Horiuchi, M; Hotta, M; Kamo, T; Narita, N; Negishi, Y; Shibahara, K; Sugihara, H; Takatsu, R; Yonenami, K | 1 |
| Edouard, AR; Incagnoli, P; Jacolot, A; Mimoz, O; Petitjean, O; Samii, K; Tod, M | 1 |
| Iwase, M; Kaburaki, J; Kamikawara, M; Kikuchi, H; Konosu, Y; Uehara, S; Yamada, M | 1 |
| Atchison, KP; Atwal, H; Higashitani, F; Hyodo, A; Kunugita, C; Maiti, SN; Micetich, RG; Nishida, K; Phillips, OA; Salama, SM; Spevak, P; Uji, T; Unemi, N | 1 |
| Hirst, RG; Norton, RE; Ulett, GC | 1 |
| Hoogkamp-Korstanje, JA; Schouten, MA; Voss, A | 1 |
| Aswapokee, N; Bowonwatanuwong, C; Chayakul, P; Chetchotisakd, P; Dusitnanond, V; Kulpradist, SA; Leelasupasri, S; Rajanuwong, A; Suttinont, C; Suwangool, P | 1 |
| Breilh, D; Cony-Makhoul, P; Ducint, D; Fratta, A; Lavallee, C; Saux, MC | 1 |
| Alzner, E; Egger, SF; Elmenyawi, I; Georgopoulos, A; Georgopoulos, M; Grabner, G; Huber-Spitzy, V | 1 |
| Fijen, JW; Ligtenberg, JJ; Möller, AV; Spanjersberg, R; Stegeman, CA; Tulleken, JE; Van de Merbel, NC; Van der Werf, TS; Zijlstra, JG | 1 |
| Bollet, C; Bornet, C; Bosi, C; Davin-Regli, A; Pages, JM | 1 |
| Arahori, K; Furui, K; Furuta, N; Hashiyama, T; Hattori, S; Hayasaki, Y; Hirose, R; Hua, YX; Ito, M; Iwasa, S; Izumi, K; Kawazoe, K; Mikamo, H; Morishita, S; Nakagawa, M; Nomura, M; Ohnishi, N; Sakakibara, K; Sato, Y; Shiraki, S; Sugiyama, M; Tamaya, T; Tsukahara, Y; Watanabe, K; Yamada, Y | 1 |
| Giamarellos-Bourboulis, EJ; Giamarellou, H; Grecka, P; Tsitsika, A; Tympanidou, C | 1 |
| Brunner, M; Delacher, S; Eichler, HG; Erovic, B; Hollenstein, U; Mayer, BX; Müller, M | 1 |
| Banyai, M; El-Menyawi, I; Heinz, G; Siostrzonek, P; Thalhammer, F; Traunmüller, F | 1 |
| Brunner, M; Eichler, HG; Hollenstein, U; Mayer, BX; Müller, M | 1 |
| Siostrzonek, P; Thalhammer, F | 1 |
| Stegeman, CA; van der Werf, TS | 1 |
| Allouch, PY; Chardon, H; Lallali, AK; Pangon, B; Pina, P; Rio, Y | 1 |
| Arakawa, S; Fujii, A; Hazama, M; Imanishi, O; Ito, N; Ka, S; Kamidono, S; Kawabata, G; Kominami, M; Kondo, K; Maruyama, S; Matsui, T; Matsumoto, H; Matsumoto, O; Minayoshi, K; Mizuno, Y; Morisue, K; Nagata, H; Nakamura, I; Ohbe, S; Okamoto, Y; Shinozaki, M; Tanaka, H; Tanaka, K; Tsuji, T; Umezu, K; Yamashita, M; Yosiyuki, K | 1 |
| Ahmed, A; Hafeez, S; Izhar, M; Naeem, M; Zafar, A | 1 |
| Atsumi, K; Ida, T; Iwamatsu, K; Kano, Y; Kobayashi, K; Kudo, T; Sato, Y; Shiokawa, S; Takizawa, H; Tamura, A; Umemura, E | 1 |
| Arlet, G; Barnaud, G; Labia, R; Philippon, A; Raskine, L; Sanson-Le Pors, MJ | 1 |
| Bergeret, M; Raymond, J | 1 |
| Fraenkel, D; Lipman, J; Rickard, CM; Wallis, SC | 1 |
| Aubert, G; Carricajo, A; Vermesch, R | 1 |
| Chimura, T; Hirayama, T; Morizaki, N; Murayama, K; Numazaki, M; Oda, T; Ogawa, T | 1 |
| Nikaido, H; Raimondi, A; Sisto, F | 1 |
| Bauduer, F; Boiron, JM; Boulat, O; Cousin, T; Fegueux, N; Jourdan, E; Molina, L; Reiffers, J; Rigal-Huguet, F | 1 |
| Koga, M; Oh-i, T; Oyake, S | 1 |
| Beader, N; Bedenić, B; Zagar, Z | 1 |
| Frossard, M; Herkner, H; Joukhadar, C; Klein, N; Kreischitz, N; Lackner, E; Mayer, BX; Müller, M; Müller, MR | 1 |
| Andrieu, P; Archambaud, M; Bonnet, E; Chabanon, G; Chaminade, B; Conil, JM; Cougot, P; Decun, JF; Georges, B; Houin, G; Roche, C; Saivin, S; Samii, K; Virenque, C | 1 |
| Hayashi, H; Huji, T; Ishikawa, M; Katayama, H; Kojima, T; Nakata, T; Yamashita, T | 1 |
| Delle-Karth, G; Heinz, G; Joukhadar, C; Klein, N; Kreischitz, N; Mayer, BX; Müller, M; Palkovits, P | 1 |
| Karasawa, T; Kuriyama, T; Nakagawa, K; Nakamura, S; Yamamoto, E | 1 |
| Evagelou, V; Koupparis, M; Tsantili-Kakoulidou, A | 1 |
| Georgopoulos, A; Heinz, G; Joukhadar, C; Marsik, C; Müller, M; Zeitlinger, MA | 1 |
| Bedenic, B; Vranes, J | 1 |
| Maier, A; Smolle-Jüttner, FM; Tomaselli, F | 1 |
| Boots, RJ; Lipman, J; Wallis, SC | 1 |
| Akiyama, K; Endo, H; Hiramatsu, N; Koyama, T; Nishinari, C; Suzuki, Y | 1 |
| Bretschneider, B; Härtl, A; Mrestani, Y; Neubert, RH | 1 |
| Fischer, M; Georgopoulos, A; Heinz, G; Joukhadar, C; Langenberger, H; Marsik, C; Mayer, BX; Müller, M; Steiner, IM | 1 |
| Hoshinaga, K; Ishikawa, K; Miyakawa, S; Naide, Y; Shiroki, R; Tanaka, T | 1 |
| Bemer, P; Drugeon, H; Mammeri, H; Nordmann, P; Poirel, L | 1 |
| Bollet, C; Bornet, C; Davin-Régli, A; Pagès, JM; Thiolas, A | 1 |
| Bergeret, M; Boutros, N; Raymond, J | 1 |
| Tumah, HN | 1 |
| Delle-Karth, G; Georgopoulos, A; Joukhadar, C; Marsik, C; Mayer-Helm, BX; Müller, M; Sauermann, R; Steiner, I; Zeitlinger, M | 1 |
| Huijgens, PC; Simoons-Smit, AM; Swart, EL; Timmers, GJ; van Vuurden, DG | 1 |
| Kotsev, Iu; Nikolovski, M; Panchev, P | 1 |
| Luczak, M; Rokosz, A; Sawicka-Grzelak, A | 1 |
| Fabius, GT; Jeronimus, A; Niël-Weise, B | 1 |
| Härtl, A; Mrestani, Y; Neubert, RH | 1 |
| Giaginis, C; Koufopoulou, SA; Pistos, C; Tsantili-Kakoulidou, A | 1 |
| Arayne, MS; Nawaz, M; Sultana, N | 1 |
| Bilewska, A; Dukaczewska, A; Goławski, C; Kicman, A; Luczak, M; Młynarczyk, A; Młynarczyk, G; Pupek, J; Serafin, I | 1 |
| Arakawa, S; Deguchi, T; Egashira, T; Fujime, M; Fujita, K; Fukuhara, Y; Furuya, N; Hirakata, Y; Hirose, T; Igari, J; Imafuku, Y; Ishibashi, K; Ishihara, S; Kamidono, S; Kitamura, M; Kobayashi, Y; Kohno, S; Kondo, A; Konishi, T; Kumamoto, Y; Kumon, H; Kunishima, Y; Matsuda, J; Matsuda, S; Matsukawa, M; Matsumoto, T; Monden, K; Murai, M; Muratani, T; Naito, S; Nakano, M; Oguri, T; Oka, T; Ooe, H; Sato, S; Shigeta, S; Suzutani, T; Tsukamoto, T; Uchida, H; Watanabe, K; Yamaguchi, K; Yamaguti, O; Yoshida, H | 1 |
| Dumka, VK; Rajput, N; Sandhu, HS | 1 |
| Chang, MC; Chang, YF; Huang, CY; Peng, MY; Sheu, YT; Su, YC; Tsao, SM; Wang, SM; Wu, MF; Yeh, KM | 1 |
| Kirkpatrick, CMJ; Lipman, J; Roos, JF | 1 |
| Arayne, MS; Sultana, N | 1 |
| Ahmed, AM; Shimamoto, T | 1 |
| Steiner, I; Wagner, CC; Zeitlinger, M | 1 |
| Behbood, L; Härtl, A; Mrestani, Y; Neubert, RH | 1 |
| Doumith, M; Ellington, MJ; Hornsey, M; Hudson, S; Livermore, DM; Woodford, N | 1 |
| Arhin, FF; Beaulieu, S; Belley, A; McKay, G; Moeck, G; Parr, TR; Sarmiento, I | 1 |
| Mahatthanatrakul, W; Sriwiriyajan, S | 1 |
| Dittrich, P; Graninger, W; Joukhadar, C; Kugler, SA; Lindenmann, J; Maier, A; Matzi, V; Porubsky, C; Smolle-Jüttner, FM | 1 |
| Bulitta, JB; Holzgrabe, U; Kinzig, M; Landersdorfer, CB; Sörgel, F; Stephan, U | 1 |
| Jain, R | 1 |
| Beceiro, A; Bou, G; Dhanji, H; Doumith, M; Downie, G; Doyle, M; Gaulton, T; Hickey, M; Livermore, DM; Maharjan, S; Soares, NC; Warner, M; Woodford, N | 1 |
| Gonçalves-Pereira, J; Póvoa, P | 1 |
| Graf, JF; Scholz, BJ; Zavodszky, MI | 1 |
| Böhmdorfer, M; Feurstein, T; Jäger, W; Karch, R; Kjellsson, MC; Langenberger, H; Püspök, A; Sauermann, R; Wild, T; Winkler, S; Zeitlinger, M | 1 |
| Anbarasu, A; Kumar, KM; Lavanya, P; Ramaiah, S | 1 |
| Cielecka-Piontek, J; Skibiński, R; Zalewski, P | 1 |
| Abbas, HF; Arayne, MS; Nawaz, M; Sultana, N | 1 |
| Ahmed, S; Ali, SA; Arsalan, A; Naqvi, SB; Shakeel, O | 1 |
| Cielecka-Piontek, J; Garbacki, P; Paczkowska, M; Skibiński, R; Talaczyńska, A; Zalewski, P | 1 |
| Han, R; Li, G; Liu, B; Zhang, Q | 1 |
| Bednarski, W; Cielecka-Piontek, J; Kozak, M; Pietralik, Z; Piotrowska, H; Skibiński, R; Szymanowska-Powałowska, D; Zalewski, P | 1 |
| Cheng, JS; Jiang, JL; Kong, XX; Liu, H; Qiao, B; Yuan, YJ | 1 |
| Hishinuma, T; Kirikae, T; Shimojima, M; Tada, T; Uchida, H | 1 |
| Chang, MJ; Hahn, J; Jang, JY; Kang, S; Kim, D; Lee, JY; Min, KL; Wi, J; Yang, S | 1 |
| Chen, S; Feng, L; Tan, B; Tao, B; Tian, W; Xiang, B; Zhang, S | 1 |
| Ren, X; Wang, J; Zhou, J | 1 |
15 review(s) available for cephalosporin c and hr 810
| Article | Year |
|---|---|
Single- and multiple-dose pharmacokinetics of intravenous cefpirome (HR810) to healthy volunteers.
Topics: Adult; Blood Pressure; Body Temperature; Cefpirome; Cephalosporins; Drug Administration Schedule; Humans; Infusions, Intravenous; Male; Middle Aged | 1992 |
Toxicity of cefpirome: an overview.
Topics: Animals; Cefpirome; Cephalosporins; Drug Administration Schedule; Drug Evaluation, Preclinical; Lethal Dose 50 | 1992 |
[new antimicrobial agent, cefpirome].
Topics: Animals; Bacteria; Bacterial Infections; Cefpirome; Cephalosporins; Drug Resistance, Microbial; Humans; Infusions, Intravenous; Injections, Intravenous | 1994 |
Cefpirome clinical pharmacokinetics.
Topics: Animals; Bacteria; Cefpirome; Cephalosporins; Humans | 1993 |
A review of the adverse events profile of cefpirome.
Topics: Cefpirome; Cephalosporins; Diarrhea; Humans; Skin Diseases | 1993 |
The pharmacokinetics of cefpirome--rationale for a twelve-hour dosing regimen.
Topics: Adult; Age Factors; Aged; Bacteria; Cefpirome; Cephalosporins; Cystic Fibrosis; Drug Administration Routes; Drug Administration Schedule; Humans; Infections; Kidney Diseases; Liver Diseases; Middle Aged | 1993 |
The chemistry and structure-activity relationships of C3-quaternary ammonium cephem antibiotics.
Topics: Amines; Cefepime; Cefpirome; Cephalosporins; Microbial Sensitivity Tests; Quaternary Ammonium Compounds; Structure-Activity Relationship | 1996 |
Tissue penetration of the fourth generation parenteral cephalosporins.
Topics: Animals; Body Fluids; Cefepime; Cefpirome; Ceftazidime; Cephalosporins; Humans; Infusions, Parenteral; Tissue Distribution | 1996 |
Diffusion of 3-quaternary ammonium cephem antibiotics into cerebrospinal fluid of patients with bacterial meningitis.
Topics: Animals; Blood-Brain Barrier; Cefepime; Cefpirome; Cephalosporins; Clinical Trials as Topic; Humans; Meningitis, Bacterial; Microbial Sensitivity Tests | 1996 |
Clinical experience with the fourth generation cephalosporins.
Topics: Bacterial Infections; Cefepime; Cefpirome; Cephalosporins; Clinical Trials as Topic; Humans; Respiratory Tract Infections; Urinary Tract Infections | 1996 |
The position of recently developed broad-spectrum cephem antibiotics in bacterial septicemia.
Topics: Bacteremia; Bacteria; Bacterial Infections; Cefepime; Cefpirome; Cephalosporins; Clinical Trials as Topic; Humans; In Vitro Techniques; Microbial Sensitivity Tests | 1996 |
[Cefpirome-- a new 4th generation cephalosporin antibiotic].
Topics: Aging; Cefpirome; Cephalosporins; Dose-Response Relationship, Drug; Humans; Intestinal Absorption; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Tissue Distribution | 1996 |
Cefpirome. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy in the treatment of severe nosocomial infections and febrile neutropenia.
Topics: Animals; Bacterial Infections; Cefpirome; Cephalosporins; Fever; Humans; Neutropenia | 1997 |
The clinical potential of fourth-generation cephalosporins.
Topics: Bacterial Infections; Cefepime; Cefpirome; Cephalosporins; Clinical Trials as Topic; Humans; Microbial Sensitivity Tests; Streptococcus pneumoniae | 1998 |
Antibiotics in critically ill patients: a systematic review of the pharmacokinetics of β-lactams.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefepime; Cefpirome; Ceftazidime; Cephalosporins; Critical Illness; Humans; Imipenem; Infections; Meropenem; Piperacillin; Thienamycins | 2011 |
42 trial(s) available for cephalosporin c and hr 810
| Article | Year |
|---|---|
Lack of interaction between cefpirome and alcohol.
Topics: Adult; Alcohol Drinking; Cefpirome; Cephalosporins; Drug Interactions; Ethanol; Humans; Male; Single-Blind Method | 1992 |
Safety, tolerance and pharmacokinetics of cefpirome administered intramuscularly to healthy subjects.
Topics: Adult; Cefpirome; Cephalosporins; Drug Administration Schedule; Humans; Injections, Intramuscular; Male | 1992 |
Prospective randomized phase II study of intravenous cefpirome 1g or 2g bd in the treatment of hospitalized patients with different infections. Cefpirome Study Group.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; Cefpirome; Cephalosporins; Cross Infection; Dose-Response Relationship, Drug; Drug Evaluation; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Prospective Studies | 1992 |
Cefpirome versus ceftazidime in the treatment of urinary tract infections.
Topics: Cefpirome; Ceftazidime; Cephalosporins; Drug Administration Schedule; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Middle Aged; Urinary Tract Infections | 1992 |
Interference of cefpirome with the measurement of plasma creatinine.
Topics: Cefpirome; Cephalosporins; Creatinine; Humans | 1991 |
Relationship between cefpirome clearance, serum creatinine, weight and age in patients treated for infection.
Topics: Adult; Age Factors; Aged; Bacterial Infections; Body Weight; Cefpirome; Cephalosporins; Creatinine; Female; Humans; Injections, Intravenous; Male; Metabolic Clearance Rate; Middle Aged | 1991 |
[Laboratory and clinical studies on cefpirome in pediatrics].
Topics: Bacterial Infections; Cefpirome; Cephalosporins; Child; Child, Preschool; Female; Humans; Infant; Infusions, Intravenous; Male | 1991 |
[Comparative study of cefpirome and ceftazidime in complicated urinary tract infections].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents, Urinary; Bacterial Infections; Cefpirome; Ceftazidime; Cephalosporins; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Urinary Tract Infections | 1991 |
[Bacteriological, pharmacokinetic and clinical evaluations of cefpirome sulfate in the pediatric field. Pediatric Study Group of Cefpirome].
Topics: Adolescent; Age Factors; Bacteria; Bacterial Infections; Cefpirome; Cephalosporins; Child; Child, Preschool; Drug Resistance, Microbial; Humans; Infant | 1991 |
[An optimum dose-finding study of HR810 (CPR) in chronic respiratory tract infections].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cefpirome; Ceftazidime; Cephalosporins; Chi-Square Distribution; Chronic Disease; Drug Evaluation; Female; Humans; Male; Middle Aged; Random Allocation; Respiratory Tract Infections | 1991 |
[A comparative study between cefpirome (CPR) and ceftazidime (CAZ) in respiratory tract infections].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cefpirome; Ceftazidime; Cephalosporins; Female; Humans; Male; Middle Aged; Respiratory Tract Infections | 1991 |
[In vitro antibacterial activity of cefpirome: a new cephalosporin; results of a multicenter study].
Topics: Cefpirome; Cephalosporins; Dose-Response Relationship, Drug; Enterobacteriaceae; Gram-Negative Aerobic Bacteria; Gram-Positive Bacteria; Haemophilus; In Vitro Techniques; Moraxella catarrhalis | 1994 |
Penetration of cefpirome into sputum in chronic respiratory infections: comparison of administration of 0.5 g and 1.0 g in the same patient.
Topics: Adult; Aged; Cefpirome; Cephalosporins; Chronic Disease; Dose-Response Relationship, Drug; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Respiratory Tract Infections; Sputum | 1993 |
Cefpirome: efficacy in the treatment of urinary and respiratory tract infections and safety profile.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefpirome; Cephalosporins; Double-Blind Method; Female; Humans; Male; Middle Aged; Respiratory Tract Infections; Single-Blind Method; Urinary Tract Infections | 1993 |
Efficacy of cefpirome in the treatment of septicaemia.
Topics: Anti-Bacterial Agents; Bacteremia; Bacteria; Bacterial Infections; Cefpirome; Cephalosporins; Double-Blind Method; Humans; Microbial Sensitivity Tests; Single-Blind Method | 1993 |
[Clinical evaluation of cefpirome sulfate for severe infections in patients with hematological disorders. Hanshin Study Group of Hematopoietic Disorders and Infections].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; Cefpirome; Cephalosporins; Drug Therapy, Combination; Female; Granulocyte Colony-Stimulating Factor; Hematologic Diseases; Humans; Injections, Intravenous; Male; Middle Aged; Opportunistic Infections | 1997 |
Characterization of peripheral-compartment kinetics of antibiotics by in vivo microdialysis in humans.
Topics: Adipose Tissue; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Cefotaxime; Cefpirome; Cellulitis; Cephalosporins; Erythromycin; Female; Fleroxacin; Humans; Macrolides; Male; Microdialysis; Muscle, Skeletal; Skin | 1996 |
[Treatment of patients with pneumonia, chronic obstructive bronchitis and mucoviscidosis with cefpirome].
Topics: Adolescent; Adult; Aged; Bacterial Infections; Bronchitis; Cefpirome; Cephalosporins; Chronic Disease; Cystic Fibrosis; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Bacterial; Pseudomonas aeruginosa; Staphylococcus; Treatment Outcome | 1996 |
[Experience using cefpirome in pneumonia].
Topics: Adult; Bacterial Infections; Bronchitis; Cefpirome; Cephalosporins; Chronic Disease; Female; Humans; Male; Microbial Sensitivity Tests; Pneumonia, Bacterial; Treatment Outcome | 1996 |
[Experience using cefpirome in patients with infections of the bronchopulmonary system].
Topics: Acute Disease; Adolescent; Adult; Agammaglobulinemia; Bacterial Infections; Bronchitis; Cefpirome; Cephalosporins; Female; Humans; Male; Middle Aged; Pneumonia, Bacterial; Treatment Outcome | 1996 |
[Use of cefpirome in the treatment of patients with skin and soft tissue infections].
Topics: Adolescent; Adult; Burns; Cefpirome; Cephalosporins; Humans; Microbial Sensitivity Tests; Middle Aged; Necrosis; Skin Diseases, Bacterial; Soft Tissue Infections; Treatment Outcome; Wound Infection | 1996 |
[Effectiveness of cefpirome in the treatment of complicated infections of the upper and lower urinary tracts].
Topics: Adolescent; Adult; Aged; Bacterial Infections; Cefotaxime; Cefpirome; Ceftazidime; Cephalosporins; Cephalothin; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Middle Aged; Treatment Outcome; Urinary Tract Infections | 1996 |
[Cefpirome--a fourth generation antibiotic for the treatment of severe hospital infections].
Topics: Adult; Cefpirome; Cephalosporins; Cross Infection; Hospitals, Municipal; Humans; Microbial Sensitivity Tests; Russia; Treatment Outcome | 1996 |
Comparison of strategies using cefpirome and ceftazidime for empiric treatment of pneumonia in intensive care patients. The Cefpirome Pneumonia Study Group.
Topics: Adult; Cefpirome; Ceftazidime; Cephalosporins; Critical Care; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Drug Tolerance; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Pneumonia, Bacterial; Prospective Studies; Treatment Outcome | 1998 |
Relationship between serum and free interstitial concentrations of cefodizime and cefpirome in muscle and subcutaneous adipose tissue of healthy volunteers measured by microdialysis.
Topics: Adipose Tissue; Adult; Area Under Curve; Cefotaxime; Cefpirome; Cephalosporins; Cross-Over Studies; Drug Monitoring; Extracellular Space; Humans; Male; Microdialysis; Muscles; Tissue Distribution | 1997 |
Clinical studies of cefpirome in the treatment of urinary tract infections caused by Enterococcus faecalis.
Topics: Cefpirome; Cephalosporins; Enterococcus faecalis; Female; Gram-Positive Bacterial Infections; Humans; Japan; Male; Microbial Sensitivity Tests; Treatment Outcome; Urinary Tract Infections | 1998 |
Cefpirome versus ceftazidime as empirical sepsis treatment. The Study Group.
Topics: Adult; Cefpirome; Ceftazidime; Cephalosporins; Chi-Square Distribution; Female; Humans; Infusions, Intravenous; Male; Prognosis; Sepsis; Severity of Illness Index; Treatment Outcome | 1998 |
[Clinical evaluation of combination therapy with cefpirome and amikacin for infections associated with hematological disorders].
Topics: Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Cefpirome; Cephalosporins; Drug Therapy, Combination; Female; Hematologic Neoplasms; Humans; Immunocompromised Host; Male; Middle Aged; Treatment Outcome | 1998 |
Randomized comparative trial of cefpirome versus ceftazidime in the empirical treatment of suspected bacteraemia or sepsis. Multicentre Study Group.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; APACHE; Bacteremia; Cefpirome; Ceftazidime; Cephalosporins; Female; Humans; Male; Middle Aged; Sepsis | 1998 |
Efficacy and safety of twice daily administration of cefpirome in the empiric treatment of sepsis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacteremia; Cefpirome; Cephalosporins; Drug Administration Schedule; Female; Follow-Up Studies; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Treatment Outcome | 1999 |
Penetration of cefpirome into the anterior chamber of the human eye after intravenous application.
Topics: Aged; Aged, 80 and over; Anterior Chamber; Aqueous Humor; Cefpirome; Cephalosporins; Female; Humans; Injections, Intravenous; Male; Middle Aged | 2000 |
[Clinical efficacy of cefpirome sulfate against Bacteroides species, Prevotella species and Porphyromonas species. Society of Anaerobic Bacterial Infections in the fields of obstetrics and gynecology in Gifu].
Topics: Adult; Aged; Bacteroidaceae Infections; Bacteroides; Cefpirome; Cephalosporins; Drug Resistance, Microbial; Female; Genital Diseases, Female; Humans; Middle Aged; Porphyromonas; Prevotella; Treatment Outcome | 2000 |
Target site concentrations after continuous infusion and bolus injection of cefpirome to healthy volunteers.
Topics: Adult; Bacterial Infections; Cefpirome; Cephalosporins; Cross-Over Studies; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Microbial Sensitivity Tests; Reference Values; Tissue Distribution | 2000 |
[A comparative study on the clinical utility of cefozopran and cefpirome against complicated urinary tract infections].
Topics: Adult; Aged; Aged, 80 and over; Cefozopran; Cefpirome; Cephalosporins; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Treatment Outcome; Urinary Tract Infections | 2000 |
A randomized prospective multicentre trial of cefpirome versus piperacillin-tazobactam in febrile neutropenia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anemia, Aplastic; Cefpirome; Cephalosporins; Enzyme Inhibitors; Female; Fever; France; Hematologic Neoplasms; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Myelodysplastic Syndromes; Neutropenia; Penicillanic Acid; Piperacillin; Tazobactam; Treatment Outcome | 2001 |
Closed-chest microdialysis to measure antibiotic penetration into human lung tissue.
Topics: Aged; Area Under Curve; Cefpirome; Cephalosporins; Equipment Design; Extracellular Space; Feasibility Studies; Humans; Lung; Male; Microbial Sensitivity Tests; Microdialysis; Middle Aged; Time Factors | 2002 |
[Importance of a cefpirome-vancomycin combination on bactericidal kinetics in severe MRSA infections in intensive care].
Topics: Adult; Aged; Bacteremia; Cefpirome; Cephalosporins; Critical Care; Drug Therapy, Combination; Female; Humans; Male; Methicillin Resistance; Middle Aged; Pneumonia, Bacterial; Prospective Studies; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2002 |
Cefpirome sulphate for gynaecological infections and prophylaxis of non-laparotomy surgery in patients with benign disease.
Topics: Adult; Aged; Antibiotic Prophylaxis; Bacterial Infections; Cefmetazole; Cefpirome; Cephalosporins; Female; Genital Diseases, Female; Humans; Middle Aged | 2002 |
Cefepime versus cefpirome: the importance of creatinine clearance.
Topics: Area Under Curve; Cefepime; Cefpirome; Cephalosporins; Chromatography, High Pressure Liquid; Creatinine; Critical Care; Half-Life; Humans; Infusions, Intravenous | 2003 |
Effect of norepinephrine on cefpirome tissue concentrations in healthy subjects.
Topics: Adult; Area Under Curve; Blood Pressure; Calibration; Cefpirome; Cephalosporins; Cross-Over Studies; Double-Blind Method; Forearm; Half-Life; Hemodynamics; Humans; Male; Microdialysis; Muscle, Skeletal; Norepinephrine; Regional Blood Flow; Skin; Vasoconstrictor Agents | 2004 |
Cefpirome as empirical treatment for febrile neutropenia in patients with hematologic malignancies.
Topics: Aged; Anti-Bacterial Agents; Cefpirome; Cephalosporins; Female; Fever; Hematologic Neoplasms; Humans; Male; Middle Aged; Neutropenia | 2005 |
An observational study on the empiric use of cefpirome in febrile neutropenia.
Topics: Anti-Bacterial Agents; Cefpirome; Cephalosporins; Endpoint Determination; Fever; Humans; Injections, Intravenous; Leukocyte Count; Male; Middle Aged; Neutropenia; Neutrophils; Taiwan; Time Factors; Treatment Outcome | 2007 |
283 other study(ies) available for cephalosporin c and hr 810
| Article | Year |
|---|---|
Molecular and biochemical characterization of the chromosome-encoded class A beta-lactamase BCL-1 from Bacillus clausii.
Topics: Amino Acid Sequence; Bacillus; Bacterial Proteins; beta-Lactamases; Chromosome Mapping; Chromosomes, Bacterial; Cloning, Molecular; Microbial Sensitivity Tests; Molecular Sequence Data; Molecular Weight; Sequence Homology, Amino Acid; Substrate Specificity | 2007 |
Computational analysis of structure-based interactions and ligand properties can predict efflux effects on antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactams; Computational Biology; Drug Resistance, Bacterial; Hydrophobic and Hydrophilic Interactions; Ligands; Membrane Transport Proteins; Microbial Sensitivity Tests; Models, Molecular; Protein Binding; Protein Conformation; Quantitative Structure-Activity Relationship; Regression Analysis; Thermodynamics | 2012 |
In vitro activity of cefpirome (HR 810) against enterococci and staphylococci.
Topics: Anti-Bacterial Agents; Cefpirome; Cephalosporins; Enterococcus faecalis; Microbial Sensitivity Tests; Species Specificity; Staphylococcus; Vancomycin | 1992 |
MIC quality control guidelines for Haemophilus susceptibility tests using cefdinir (FK482), cefepime, cefetamet, cefpirome, ceftibuten, fleroxacin, temafloxacin, clarithromycin, RP59500, and trospectomycin.
Topics: Anti-Bacterial Agents; Cefdinir; Cefpirome; Ceftibuten; Ceftizoxime; Cephalosporins; Clarithromycin; Erythromycin; Fleroxacin; Fluoroquinolones; Haemophilus; Humans; Microbial Sensitivity Tests; Quality Control; Quinolones; Spectinomycin; Virginiamycin | 1992 |
Antibacterial activity in vitro of cefpirome against clinical isolates causing sexually transmitted diseases.
Topics: Cefpirome; Cephalosporins; Chancroid; Chlamydia; Chlamydia Infections; Gardnerella vaginalis; Gonorrhea; Haemophilus ducreyi; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillins; Quinolones; Sexually Transmitted Diseases, Bacterial | 1992 |
Serum creatinine assays in patients receiving the antibiotic Cefpirome (HR 810): a study of three different routine methods compared with a specific HPLC method.
Topics: Cefpirome; Cephalosporins; Chromatography, High Pressure Liquid; Clinical Enzyme Tests; Creatinine; Humans | 1992 |
Cefpirome: a novel extended spectrum cephalosporin. Proceedings of the 17th International Congress of Chemotherapy. Berlin, Germany, 23-28 June 1991.
Topics: Animals; Cefpirome; Cephalosporins; Humans | 1992 |
Activity of cefpirome combined with beta-lactamase inhibitors and affinity for the penicillin-binding proteins of methicillin-resistant Staphylococcus aureus.
Topics: Bacterial Proteins; beta-Lactamase Inhibitors; Carrier Proteins; Cefpirome; Ceftazidime; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Drug Synergism; Hexosyltransferases; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Mutation; Penicillin-Binding Proteins; Peptidyl Transferases; Staphylococcus aureus; Sulbactam | 1992 |
Comparative study of pharmacokinetics and serum bactericidal activities of cefpirome, ceftazidime, ceftriaxone, imipenem, and ciprofloxacin.
Topics: Adult; Cefpirome; Ceftazidime; Ceftriaxone; Cephalosporins; Chromatography, High Pressure Liquid; Ciprofloxacin; Half-Life; Humans; Imipenem; Male; Microbial Sensitivity Tests | 1992 |
Comparative pharmacokinetics of SCE-2787 and related antibiotics in experimental animals.
Topics: Animals; Anti-Bacterial Agents; Biliary Tract; Blood Proteins; Cefozopran; Cefpirome; Ceftazidime; Cephalosporins; Dogs; Drug Administration Schedule; Female; Macaca fascicularis; Male; Mice; Mice, Inbred ICR; Protein Binding; Rabbits; Rats; Rats, Sprague-Dawley; Species Specificity | 1992 |
Comparative in-vitro activities of newer cephalosporins cefclidin, cefepime, and cefpirome against ceftazidime- or imipenem-resistant Pseudomonas aeruginosa.
Topics: beta-Lactamases; Cefepime; Cefpirome; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Humans; Imipenem; Isoelectric Focusing; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 1992 |
Studies on condensed-heterocyclic azolium cephalosporins. III. Synthesis and antibacterial activity of 7 beta-[2-(2-amino-5-substituted-thiazol-4-yl)-2 (Z)-alkoxyiminoacetamido]-3-(condensed-heterocyclic azolium)methyl-3-cephem-4- carboxylates.
Topics: Anti-Bacterial Agents; Cefmenoxime; Cefpirome; Cephalosporins; Gram-Negative Bacteria; Gram-Positive Bacteria; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests | 1992 |
The in-vitro antibacterial activity of a combination of cefpirome or cefoperazone with vancomycin against enterococci and Staphylococcus aureus.
Topics: Cefoperazone; Cefpirome; Cephalosporins; Drug Therapy, Combination; Enterococcus; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus aureus; Vancomycin | 1992 |
Pharmacokinetics of cefpirome administered intravenously or intramuscularly to rats and dogs.
Topics: Animals; Biological Availability; Cefpirome; Cephalosporins; Dogs; Dose-Response Relationship, Drug; Injections, Intramuscular; Injections, Intravenous; Male; Rats; Rats, Inbred Strains | 1992 |
Cerebrospinal fluid penetration of cefpirome in patients with non-inflamed meninges.
Topics: Adolescent; Adult; Aged; Anesthesia, Spinal; Cefpirome; Cephalosporins; Female; Humans; Male; Meninges; Meningitis; Middle Aged; Myelography; Spinal Puncture | 1992 |
Diffusion of cefpirome into the cerebrospinal fluid of patients with purulent meningitis.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Cefpirome; Cephalosporins; Diffusion; Female; Humans; Male; Meningitis, Pneumococcal; Middle Aged | 1992 |
In-vitro activity of cefpirome against isolates from patients with urinary tract, lower respiratory tract and wound infections.
Topics: Anti-Bacterial Agents; Cefpirome; Cephalosporins; Enterobacteriaceae; Humans; Microbial Sensitivity Tests; Pseudomonas; Respiratory Tract Infections; Staphylococcus aureus; Urinary Tract Infections; Wound Infection | 1992 |
Comparison of clinical response to cefpirome treatment and minimum inhibitory concentration of causative isolates. Microbiological and Clinical Study Groups.
Topics: Bacteria; Cefpirome; Cephalosporins; Enterococcus; Escherichia coli; Humans; Klebsiella; Microbial Sensitivity Tests; Multicenter Studies as Topic; Pneumonia; Pseudomonas aeruginosa; Urinary Tract Infections | 1992 |
Influence of cefpirome on pharyngeal and faecal flora after single and multiple intravenous administrations of cefpirome to healthy volunteers.
Topics: Adult; Candida; Cefpirome; Cephalosporins; Drug Administration Schedule; Drug Resistance, Microbial; Escherichia coli; Feces; Humans; Infusions, Intravenous; Male; Pharynx; Streptococcus | 1992 |
Microanalytical high-performance liquid chromatographic assay for cefpirome in human milk and urine.
Topics: Cefpirome; Cephalosporins; Chromatography, High Pressure Liquid; Female; Humans; Lactation; Milk, Human; Spectrophotometry, Ultraviolet | 1992 |
Single-dose pharmacokinetics of cefpirome in patients with renal impairment.
Topics: Adult; Aged; beta 2-Microglobulin; Cefpirome; Cephalosporins; Creatinine; Drug Tolerance; Female; Half-Life; Humans; Kidney Diseases; Male; Metabolic Clearance Rate; Middle Aged | 1992 |
Antibacterial properties of SCE-2787, a new cephem antibiotic.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Carrier Proteins; Cefozopran; Cefpirome; Ceftazidime; Cephalosporins; Escherichia coli; Hexosyltransferases; Microbial Sensitivity Tests; Microscopy; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases; Protein Binding; Pseudomonas aeruginosa; Staphylococcus aureus | 1992 |
In vitro activity and stability against novel beta-lactamases of investigational beta-lactams (cefepime, cefpirome, flomoxef, SCE2787 and piperacillin plus tazobactam) in comparison with established compounds (cefotaxime, latamoxef and piperacillin).
Topics: Anti-Bacterial Agents; beta-Lactamases; Cefotaxime; Cefozopran; Cefpirome; Cephalosporins; Drug Stability; Enterobacteriaceae; Hydrolysis; Microbial Sensitivity Tests; Moxalactam; Penicillanic Acid; Piperacillin; Tazobactam | 1991 |
Susceptibility testing of cefpirome.
Topics: Cefpirome; Cephalosporins; Drug Resistance, Microbial; Microbial Sensitivity Tests | 1992 |
The penetration of cefpirome into the potential sites of pulmonary infection.
Topics: Adult; Aged; Aged, 80 and over; Bronchoalveolar Lavage Fluid; Cefpirome; Cephalosporins; Epithelium; Female; Humans; Lung; Male; Middle Aged; Mucous Membrane; Respiratory Tract Infections | 1991 |
beta-Lactamase expression and outer membrane protein changes in cefpirome-resistant and ceftazidime-resistant gram-negative bacteria.
Topics: Bacterial Outer Membrane Proteins; beta-Lactamases; Cefpirome; Ceftazidime; Cephalosporins; Enterobacteriaceae; Microbial Sensitivity Tests; Mutation; Pseudomonas aeruginosa | 1991 |
[Pharmacokinetics of cefpirome (CPR) in patients with impaired renal function].
Topics: Aged; Cefpirome; Cephalosporins; Female; Humans; Kidney; Kidney Diseases; Male; Middle Aged | 1991 |
In vitro and in vivo antibacterial activities of ME1220 and ME1221, novel cephalosporins.
Topics: Animals; beta-Lactamases; Cefpirome; Ceftazidime; Cephalosporins; Gram-Negative Bacteria; Gram-Positive Bacteria; Male; Mice; Mice, Inbred ICR; Rats; Rats, Inbred Strains | 1991 |
[A study on the disc sensitivity test for cefpirome].
Topics: Cefpirome; Cephalosporins; Microbial Sensitivity Tests | 1991 |
Comparison of cefepime, cefpirome, and cefaclidine binding affinities for penicillin-binding proteins in Escherichia coli K-12 and Pseudomonas aeruginosa SC8329.
Topics: Bacterial Proteins; beta-Lactamases; Carrier Proteins; Cefepime; Cefpirome; Cell Membrane; Cephalosporins; Escherichia coli; Hexosyltransferases; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases; Protein Binding; Pseudomonas aeruginosa | 1991 |
[Pharmacokinetic and clinical studies of cefpirome in pediatric field].
Topics: Adolescent; Bacterial Infections; Cefpirome; Cephalosporins; Child; Child, Preschool; Drug Eruptions; Drug Evaluation; Eosinophilia; Female; Humans; Infant; Male; Thrombocytosis | 1991 |
In vitro evaluation of GR69153, a novel catechol-substituted cephalosporin.
Topics: Bacteria; Bacterial Outer Membrane Proteins; Cefpirome; Ceftazidime; Ceftriaxone; Cephalosporins; Culture Media; Drug Resistance, Microbial; Gram-Negative Bacteria; Gram-Positive Bacteria; Imipenem; Microbial Sensitivity Tests; Plasmids | 1991 |
[Pharmacokinetic and clinical evaluation of cefpirome in the pediatric field].
Topics: Adolescent; Age Factors; Bacterial Infections; Cefpirome; Cephalosporins; Child; Child, Preschool; Drug Evaluation; Female; Half-Life; Humans; Infant; Infusions, Intravenous; Male | 1991 |
[Bacteriological, pharmacokinetic and clinical studies of cefpirome in the field of pediatrics].
Topics: Adolescent; Age Factors; Bacteria; Cefpirome; Cephalosporins; Child; Child, Preschool; Drug Evaluation; Drug Resistance, Microbial; Female; Humans; Male; Pneumonia; Urinary Tract Infections | 1991 |
[Clinical evaluation of cefpirome in children].
Topics: Age Factors; Bacteria; Cefpirome; Cephalosporins; Child; Child, Preschool; Drug Evaluation; Drug Resistance, Microbial; Female; Humans; Infant; Infusions, Intravenous; Injections, Intravenous; Male; Respiratory Tract Infections | 1991 |
[Laboratory and clinical studies of cefpirome in pediatric field].
Topics: Adolescent; Age Factors; Bacteria; Cefpirome; Cephalosporins; Child; Child, Preschool; Humans; Infant; Infusions, Intravenous; Injections, Intravenous; Respiratory Tract Infections; Urinary Tract Infections | 1991 |
[Clinical evaluation of cefpirome in pediatric field].
Topics: Acute Disease; Age Factors; Cefpirome; Cephalosporins; Child, Preschool; Colitis; Drug Evaluation; Female; Humans; Infant; Injections, Intravenous; Male; Respiratory Tract Infections | 1991 |
[Clinical studies on cefpirome in pediatrics].
Topics: Adolescent; Age Factors; Bacteria; Cefpirome; Cephalosporins; Child; Child, Preschool; Drug Evaluation; Drug Resistance, Microbial; Female; Humans; Infant; Injections, Intravenous; Male; Pleurisy; Pneumonia; Urinary Tract Infections | 1991 |
[Clinical evaluation of cefpirome in pediatrics and a study on the penetration into cerebrospinal fluid].
Topics: Adolescent; Age Factors; Bacteria; Bacterial Infections; Cefpirome; Cephalosporins; Child; Child, Preschool; Drug Evaluation; Drug Resistance, Microbial; Female; Humans; Infant; Injections, Intravenous; Male | 1991 |
[Laboratory and clinical studies on cefpirome in pediatrics].
Topics: Acute Disease; Adolescent; Bacterial Infections; Bronchitis; Cefpirome; Cephalosporins; Child; Child, Preschool; Enterocolitis; Female; Humans; Infant; Male; Meningitis; Osteomyelitis; Otitis Media; Pneumonia; Scarlet Fever; Tonsillitis; Urinary Tract Infections | 1991 |
[A basic study on cefpirome].
Topics: Cefpirome; Cephalosporins; Humans; Kidney; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Prostate | 1991 |
Chronic intravenous toxicity of the new antibiotic cefpirome in monkeys.
Topics: Acetylglucosamine; Aminolevulinic Acid; Animals; beta 2-Microglobulin; Blood Cell Count; Blood Chemical Analysis; Body Weight; Cefpirome; Cephalosporins; Female; gamma-Glutamyltransferase; Injections, Intravenous; Macaca fascicularis; Macaca mulatta; Male; Organ Size | 1990 |
Novel method for measurement of outer membrane permeability to new beta-lactams in intact Enterobacter cloacae cells.
Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; beta-Lactamases; Cefpirome; Cell Membrane Permeability; Cephalosporins; Chromatography, High Pressure Liquid; Enterobacter; Hydrolysis | 1991 |
Pharmacokinetics and antibacterial efficacy of cefpirome (HR 810) in experimental Escherichia coli and Haemophilus influenzae type b meningitis.
Topics: Animals; Cefpirome; Cephalosporins; Colony Count, Microbial; Escherichia coli; Escherichia coli Infections; Haemophilus influenzae; Male; Meningitis, Haemophilus; Microbial Sensitivity Tests; Rabbits | 1991 |
[Transferability of cefpirome to cerebrospinal fluid of rabbits with meningitis caused by Staphylococcus aureus].
Topics: Animals; Cefpirome; Cephalosporins; Disease Models, Animal; Injections, Intravenous; Meningitis; Rabbits; Staphylococcal Infections | 1991 |
[The influence of cefpirome on intestinal bacterial flora].
Topics: Bacteria; beta-Lactamases; Cefpirome; Cephalosporins; Child, Preschool; Drug Resistance, Microbial; Feces; Female; Humans; Infant; Injections, Intravenous; Intestinal Mucosa; Intestines; Male | 1991 |
[Clinical evaluation of cefpirome in children].
Topics: Bacterial Infections; Cefpirome; Cephalosporins; Child; Child, Preschool; Drug Evaluation; Female; Half-Life; Humans; Infant; Male; Pneumonia, Pneumococcal | 1991 |
[Pharmacokinetic and clinical studies on cefpirome in pediatrics].
Topics: Adolescent; Bacteria; Bacterial Infections; Cefpirome; Cephalosporins; Child; Child, Preschool; Drug Evaluation; Female; Humans; Infant; Male; Microbial Sensitivity Tests | 1991 |
[Pharmacokinetic and clinical evaluation of cefpirome in the pediatric field].
Topics: Absorption; Adolescent; Bacterial Infections; Bronchopneumonia; Cefpirome; Cephalosporins; Child; Child, Preschool; Drug Evaluation; Female; Humans; Infant; Male | 1991 |
[Pharmacokinetics and clinical evaluation of cefpirome in children].
Topics: Absorption; Adolescent; Bacterial Infections; Cefpirome; Cephalosporins; Child; Child, Preschool; Drug Evaluation; Female; Haemophilus Infections; Haemophilus influenzae; Half-Life; Humans; Infant; Male; Respiratory Tract Infections; Staphylococcal Infections | 1991 |
[Pharmacokinetic and clinical study of cefpirome in children].
Topics: Adolescent; Bacterial Infections; Cefpirome; Cephalosporins; Child; Child, Preschool; Drug Evaluation; Female; Half-Life; Humans; Infant; Male; Respiratory Tract Infections; Urinary Tract Infections | 1991 |
[Pharmacokinetical and clinical study of cefpirome in children].
Topics: Adolescent; Bacteria; Bacterial Infections; Cefpirome; Cephalosporins; Child; Child, Preschool; Drug Evaluation; Female; Half-Life; Humans; Infant; Male; Microbial Sensitivity Tests; Respiratory Tract Infections | 1991 |
[Clinical efficacy of cefpirome against various infectious diseases in children].
Topics: Adolescent; Bacterial Infections; Cefpirome; Cephalosporins; Child; Child, Preschool; Drug Evaluation; Female; Humans; Infant; Male; Respiratory Tract Infections; Urinary Tract Infections | 1991 |
[Acute toxicity study of cefpirome sulfate in mice and rats].
Topics: Animals; Body Weight; Cefpirome; Cephalosporins; Female; Lethal Dose 50; Male; Mice; Mice, Inbred ICR; Rats; Rats, Inbred Strains | 1990 |
[Effects of cefpirome sulfate on male sexual development in rats].
Topics: Animals; Body Weight; Cefpirome; Cephalosporins; Fertility; Genitalia, Male; Male; Organ Size; Rats; Rats, Inbred Strains; Reproduction; Sexual Maturation; Spermatozoa | 1990 |
[Six-month intraperitoneal toxicity study of cefpirome sulfate in rats].
Topics: Animals; Blood; Body Weight; Cefpirome; Cephalosporins; Female; Injections, Intraperitoneal; Kidney; Male; Rats; Rats, Inbred Strains; Thyroid Gland | 1990 |
[Antigenicity study of cefpirome sulfate].
Topics: Anaphylaxis; Animals; Anti-Bacterial Agents; Antibody Formation; Cefpirome; Cephalosporins; Cross Reactions; Guinea Pigs; Hemagglutination Tests; Male; Passive Cutaneous Anaphylaxis; Rabbits | 1990 |
[Local irritancy study of cefpirome sulfate].
Topics: Animals; Cefpirome; Cephalosporins; Eye; Hemolysis; Irritants; Male; Muscles; Rabbits; Skin; Thrombosis | 1990 |
[Nephrotoxicity of cefpirome sulfate in rabbits--single and multiple intravenous administration].
Topics: Animals; Cefazolin; Cefpirome; Cephalosporins; Injections, Intravenous; Kidney; Liver; Male; Organ Size; Rabbits | 1990 |
[Fertility study of cefpirome sulfate in rats].
Topics: Abnormalities, Drug-Induced; Animals; Body Weight; Bone and Bones; Cefpirome; Cephalosporins; Dose-Response Relationship, Drug; Female; Fertility; Fetus; Male; Organ Size; Pregnancy; Rats; Rats, Inbred Strains | 1990 |
[Teratological study of cefpirome sulfate in rats].
Topics: Abnormalities, Drug-Induced; Animals; Body Weight; Bone and Bones; Cefpirome; Cephalosporins; Dose-Response Relationship, Drug; Female; Fetal Death; Fetus; Male; Motor Activity; Organ Size; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Inbred Strains; Reproduction | 1990 |
Subchronic and chronic toxicity of the new antibiotic cefpirome in rats.
Topics: Animals; Blood Cell Count; Blood Chemical Analysis; Body Weight; Cefpirome; Cephalosporins; Eating; Female; Liver Function Tests; Male; Organ Size; Proteinuria; Rats; Rats, Inbred Strains; Time Factors | 1990 |
In-vitro susceptibilities of gram-positive bacteria to cefpirome, vancomycin, isepamicin and gentamicin, singly and in combination.
Topics: Anti-Bacterial Agents; Cefpirome; Cephalosporins; Drug Therapy, Combination; Gentamicins; Gram-Positive Bacteria; Microbial Sensitivity Tests; Vancomycin | 1990 |
Inhibitory and bactericidal activity of cefpirome and cefotaxime against blood culture isolates.
Topics: Bacterial Infections; Bacteriological Techniques; Cefotaxime; Cefpirome; Cephalosporins; Culture Media; Enterobacter; Escherichia coli; Klebsiella; Pseudomonas aeruginosa; Staphylococcus aureus | 1990 |
In vitro activity of cefpirome (HR810) against Enterococcus species.
Topics: Cefpirome; Cephalosporins; Drug Therapy, Combination; Enterococcus faecalis; Gentamicins; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Streptococcal Infections; Streptococcus | 1990 |
The effect of rifampicin on the in-vitro activity of cefpirome or ceftazidime in combination with aminoglycosides against Pseudomonas aeruginosa.
Topics: Aminoglycosides; Anti-Bacterial Agents; Cefpirome; Ceftazidime; Cephalosporins; Drug Interactions; Drug Synergism; Drug Therapy, Combination; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Rifampin | 1990 |
Comparative therapy with cefpirome alone and in combination with rifampin and/or gentamicin against a disseminated Pseudomonas aeruginosa infection in leukopenic mice.
Topics: Animals; Cefpirome; Cephalosporins; Drug Therapy, Combination; Gentamicins; Kidney; Leukopenia; Liver; Lung; Male; Mice; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Rifampin; Spleen | 1990 |
[Perinatal and postnatal study of cefpirome sulfate in rats].
Topics: Abnormalities, Drug-Induced; Animals; Animals, Newborn; Body Weight; Cefpirome; Cephalosporins; Dose-Response Relationship, Drug; Female; Fetal Death; Fetus; Male; Motor Activity; Organ Size; Pregnancy; Rats; Rats, Inbred Strains; Reproduction | 1990 |
[Antibacterial activity of carumonam and cefpirome on hospital strains resistant to gentamicin and cephalothin: comparison with other beta-lactam antibiotics, new fluoroquinolones, aminoglycosides and other antibiotics].
Topics: Aminoglycosides; Anti-Bacterial Agents; Aztreonam; Cefpirome; Cephalosporins; Cephalothin; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Gentamicins; Gram-Negative Bacteria; In Vitro Techniques; Quinolones | 1990 |
Therapeutic effects of cefpirome, a new cephalosporin, on various models of infections in mice and rats.
Topics: Animals; Cefpirome; Cephalosporins; Escherichia coli; Female; Klebsiella Infections; Klebsiella pneumoniae; Lung Diseases; Male; Methicillin; Mice; Penicillin Resistance; Pseudomonas Infections; Pyelonephritis; Rats; Staphylococcal Infections; Staphylococcus aureus; Uterine Diseases | 1990 |
In vitro antibacterial spectrum of E1040 compared with those of cefpirome and ceftazidime and disk diffusion interpretive criteria for E1040.
Topics: Bacteria; Cefpirome; Ceftazidime; Cephalosporins; Culture Media; Microbial Sensitivity Tests | 1990 |
In vitro antibacterial activity and beta-lactamase stability of the new carbapenem LJC10,627.
Topics: Bacteria; beta-Lactamases; Carbapenems; Cefpirome; Ceftazidime; Cephalosporins; Humans; Imipenem; Molecular Structure; Thienamycins | 1990 |
Comparative in vitro activity of cefpirome and cefepime, two new cephalosporins.
Topics: Anti-Bacterial Agents; Cefepime; Cefpirome; Cephalosporins; Ciprofloxacin; Enterobacteriaceae; Gentamicins; Microbial Sensitivity Tests | 1990 |
In-vitro antibacterial activity of DQ-2556 and its stability to various beta-lactamases.
Topics: beta-Lactamases; Cefpirome; Ceftazidime; Cephalosporins; Drug Stability; Enterobacteriaceae; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests | 1990 |
Stability and degradation pattern of cefpirome (HR 810) in aqueous solution.
Topics: Cefpirome; Cephalosporins; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Drug Stability; Solutions | 1990 |
Biochemical aspects of the renal tolerance for cefpirome and other cephalosporins.
Topics: Animals; Cefotaxime; Cefpirome; Cephalosporins; Cytosol; Gluconeogenesis; Glutathione; In Vitro Techniques; Kidney Cortex; Kidney Diseases; L-Lactate Dehydrogenase; Male; Malondialdehyde; Oxidation-Reduction; Rats; Rats, Inbred Strains; Tetraethylammonium; Tetraethylammonium Compounds | 1990 |
Penetration of cefpirome into prostatic tissue.
Topics: Aged; Aged, 80 and over; Cefpirome; Cephalosporins; Half-Life; Humans; Male; Middle Aged; Premedication; Prostate; Prostatectomy | 1990 |
Comparative chemotherapeutic activity of cefpirome and imipenem in experimental infections.
Topics: Abscess; Animals; Bacterial Infections; Cefotaxime; Cefpirome; Cephalosporins; Enterobacteriaceae Infections; Escherichia coli Infections; Female; Granuloma; Imipenem; Male; Mice; Mice, Hairless; Mice, Inbred C3H; Pneumonia; Rats; Rats, Inbred Strains; Sepsis; Staphylococcal Skin Infections; Staphylococcus aureus; Streptococcal Infections | 1990 |
[Activity of cefpirome against bacteria isolated from hospitalized patients].
Topics: Anti-Bacterial Agents; Cefpirome; Cephalosporins; Cross Infection; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests | 1989 |
In-vitro and in-vivo activity of cefpirome (HR 810) against methicillin-susceptible and -resistant Staphylococcus aureus and Streptococcus faecalis.
Topics: Aminoglycosides; Ampicillin; Animals; Anti-Bacterial Agents; Cefpirome; Cephalosporins; Enterococcus faecalis; Methicillin; Mice; Microbial Sensitivity Tests; Penicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Streptococcal Infections | 1989 |
Intraperitoneal penetration of cefpirome.
Topics: Adult; Aged; Ascitic Fluid; Cefpirome; Cephalosporins; Enterobacteriaceae; Enterococcus faecalis; Half-Life; Humans; Middle Aged; Pseudomonas aeruginosa; Staphylococcus aureus | 1989 |
Interaction of cefpirome and a cephalosporinase from Citrobacter freundii GN7391.
Topics: beta-Lactamases; Cefotaxime; Cefotiam; Cefpirome; Ceftazidime; Cephalosporinase; Cephalosporins; Citrobacter; Hydrolysis; Kinetics | 1989 |
Activity of cefepime (BMY-28142) and cefpirome (HR 810) against gram-negative bacilli resistant to cefotaxime or ceftazidime.
Topics: Cefepime; Cefotaxime; Cefpirome; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Gram-Negative Bacteria | 1989 |
Beta-lactamase stability and antibacterial activity of cefpirome alone and in combination with other antibiotics.
Topics: beta-Lactamases; Cefpirome; Cephalosporins; Drug Synergism; Drug Therapy, Combination; Escherichia coli; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests | 1989 |
[Meningeal diffusion of cefpirome in adults].
Topics: Adolescent; Adult; Aged; Cefpirome; Cephalosporins; Child; Chromatography, High Pressure Liquid; Female; Humans; Male; Meninges; Meningitis; Middle Aged | 1989 |
In vitro and in vivo antibacterial activity of the new semisynthetic cephalosporin cefpirome.
Topics: Animals; Bacteria; Bacterial Infections; beta-Lactamases; Cefpirome; Cephalosporins; Drug Stability; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests | 1989 |
Comparative determination of minimal inhibitory and bactericidal concentrations of ciprofloxacin, cefotaxime and HR 810 for gram-negative bacteria either sensitive or resistant to ureidopenicillins and/or gentamicin.
Topics: Anti-Bacterial Agents; Cefotaxime; Cefpirome; Cephalosporins; Ciprofloxacin; Gentamicins; Gram-Negative Bacteria; Microbial Sensitivity Tests; Piperacillin; Quinolines | 1985 |
In-vitro evaluation of cefpirome (HR 810), teicoplanin and four other antimicrobials against enterococci.
Topics: Ampicillin; Cefpirome; Cephalosporins; Drug Combinations; Drug Synergism; Enterococcus faecalis; Glycopeptides; In Vitro Techniques; Microbial Sensitivity Tests; Piperacillin; Streptococcus; Teicoplanin; Vancomycin | 1985 |
Inducing capacity and selection of resistant variants of cefpirome (HR 810) in comparison with other beta-lactam compounds.
Topics: Cefotaxime; Cefpirome; Ceftazidime; Cephalosporins; Enterobacteriaceae; Microbial Sensitivity Tests; Penicillinase | 1988 |
In-vitro activity of cefpirome compared with that of other agents.
Topics: Anti-Bacterial Agents; Cefpirome; Cephalosporins; Drug Resistance, Microbial; Enterobacteriaceae; Humans; Pseudomonas aeruginosa | 1988 |
[In vitro antibacterial activity of cefpirome in combination with 4 aminoglycosides and 2 fluoroquinolones].
Topics: 4-Quinolones; Acinetobacter; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Cefpirome; Cephalosporins; Drug Synergism; Drug Therapy, Combination; Enterobacteriaceae; Enterococcus faecalis; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Staphylococcus aureus | 1988 |
Synthesis and structure-activity relationships in the cefpirome series. I. 7-[2-(2-Aminothiazol-4-yl)-2-(Z)-oxyiminoacetamido]-3-[(su bstituted-1-pyridinio)methyl]ceph-3-em-4-carboxylate s.
Topics: Animals; beta-Lactamases; Cefpirome; Cephalosporins; Chemical Phenomena; Chemistry; Dogs; Haplorhini; Humans; Klebsiella; Magnetic Resonance Spectroscopy; Mice; Pseudomonas aeruginosa; Staphylococcus; Structure-Activity Relationship | 1988 |
Activity of cefpirome (HR810) against Pseudomonas aeruginosa strains with characterised resistance mechanisms to beta-lactam antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cefpirome; Cephalosporins; Drug Resistance, Microbial; Enzyme Induction; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 1988 |
In vitro activity of E-1040, a novel cephalosporin with potent activity against Pseudomonas aeruginosa.
Topics: Aminoglycosides; beta-Lactamases; Cefepime; Cefpirome; Ceftazidime; Cephalosporins; Drug Resistance; Drug Stability; Gentamicins; Hydrolysis; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 1988 |
Comparative in vitro activities of aztreonam, ciprofloxacin, norfloxacin, ofloxacin, HR 810 (a new cephalosporin), RU28965 (a new macrolide), and other agents against enteropathogens.
Topics: Anti-Bacterial Agents; Aztreonam; Cefpirome; Cephalosporins; Ciprofloxacin; Enterobacteriaceae; Leucomycins; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Ofloxacin; Oxazines; Quinolines | 1985 |
Safety, tolerance and pharmacokinetics of 2.0 g cefpirome (HR 810) after single and multiple dosing.
Topics: Adult; Blood Chemical Analysis; Cefpirome; Cephalosporins; Drug Tolerance; Half-Life; Humans; Injections, Intravenous; Kidney; Kidney Function Tests; Male; Middle Aged | 1988 |
Microanalytical high-performance liquid chromatography assay for cefpirome (HR 810) in serum.
Topics: Cefpirome; Cephalosporins; Chromatography, High Pressure Liquid; Humans; Microchemistry | 1988 |
Synthesis and structure-activity relationships in the cefpirome series. II. Analogues of cefpirome with different 7-heteroarylacetamido and 3'-ammonium substituents.
Topics: Cefpirome; Cephalosporins; Chemical Phenomena; Chemistry; Enterobacter; Klebsiella; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Pseudomonas; Streptococcus; Structure-Activity Relationship | 1988 |
Synthesis and structure-activity relationships in the cefpirome series. III. 7 Alpha-methoxy and 7 alpha-formamido analogues of cefpirome.
Topics: Cefpirome; Cephalosporins; Chemical Phenomena; Chemistry; Gram-Negative Bacteria; Gram-Positive Bacteria; Magnetic Resonance Spectroscopy; Structure-Activity Relationship | 1988 |
Distribution of cefpirome (HR 810) to exudate in the croton oil-induced rat granuloma pouch and its therapeutic effects on experimental infections in the pouch.
Topics: Animals; Bacterial Infections; Cefpirome; Cephalosporins; Croton Oil; Exudates and Transudates; Granuloma; Male; Microbial Sensitivity Tests; Protein Binding; Rats; Rats, Inbred Strains | 1988 |
Efficacy and safety of cefpirome (HR810).
Topics: Adult; Aged; Aged, 80 and over; Bacterial Infections; Cefpirome; Cephalosporins; Drug Evaluation; Female; Humans; Male; Middle Aged; Pneumonia; Urinary Tract Infections | 1988 |
An in vitro evaluation of HRE 664, a novel penem antibiotic.
Topics: Anti-Bacterial Agents; Cefotaxime; Cefpirome; Cephalosporins; Drug Resistance, Microbial; Drug Stability; Lactams; Microbial Sensitivity Tests; Quality Control; Temperature | 1988 |
Pharmacokinetics and tissue penetration of cefpirome, a new cephalosporin.
Topics: Adult; Blister; Cefpirome; Cephalosporins; Half-Life; Humans; Male | 1988 |
In-vitro activity of cefpirome (HR-810), WIN-49375, BMY-28142 and other antibiotics against nosocomially important isolates from cancer patients.
Topics: Anti-Bacterial Agents; Cefepime; Cefpirome; Cephalosporins; Ciprofloxacin; Cross Infection; Fluoroquinolones; Gram-Negative Bacteria; Humans; Imipenem; Microbial Sensitivity Tests; Neoplasms; Quinolines; Thienamycins | 1986 |
Susceptibility of non-fermentative gram-negative bacteria to ciprofloxacin, norfloxacin, amifloxacin, pefloxacin and cefpirome.
Topics: Anti-Infective Agents; Cefpirome; Cephalosporins; Ciprofloxacin; Fluoroquinolones; Gram-Negative Bacteria; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Quinolines | 1986 |
Beta-lactamase stability of cefpirome (HR 810), a new cephalosporin with a broad antimicrobial spectrum.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamases; Cefpirome; Cephalosporins; Drug Stability; Enzyme Induction; R Factors | 1986 |
Structure-activity relationships in the cefpirome (HR 810) series: synthesis and antibacterial activity of 7 alpha-methoxy and 7 alpha-formylamino analogues of HR 810.
Topics: Bacteria; Cefpirome; Cephalosporins; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship | 1987 |
Comparative effects of cefpirome (HR 810) and other cephalosporins on experimentally induced pneumonia in mice.
Topics: Animals; Cefpirome; Cephalosporins; Klebsiella Infections; Klebsiella pneumoniae; Lung; Male; Mice; Mice, Inbred Strains; Pneumonia | 1986 |
[In vitro antibacterial activity of a new cephalosporin: cefpirome (HR 810). Comparison with ceftriaxone, cefotaxime, latamoxef and ceftazidime].
Topics: Bacteria; Cefotaxime; Cefpirome; Ceftazidime; Ceftriaxone; Cephalosporins; Microbial Sensitivity Tests; Moxalactam | 1986 |
Interference by the new antibiotic cefpirome and other cephalosporins in clinical laboratory tests, with special regard to the "Jaffé" reaction.
Topics: Blood Chemical Analysis; Cefpirome; Cephalosporins; Colorimetry; Creatinine; Humans; Male; Picrates | 1987 |
Comparative in-vitro activity of cefodizime, cefpirome, carumonam and RU-28965 with other antimicrobials against anaerobes.
Topics: Anti-Bacterial Agents; Aztreonam; Bacteria, Anaerobic; Cefotaxime; Cefpirome; Cephalosporins; Leucomycins; Microbial Sensitivity Tests | 1987 |
In vitro activity of cefpirome (HR810) against antibiotic-resistant gram-positive and gram-negative bacteria including organisms with inducible resistance.
Topics: Anti-Bacterial Agents; Cefpirome; Cephalosporins; Enterobacteriaceae; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Pseudomonas; Streptococcus | 1986 |
In vitro antimicrobial activity of cefpirome, a new cephalosporin with a broad antimicrobial spectrum.
Topics: Cefpirome; Cephalosporins; Culture Media; Enterobacteriaceae; Hydrogen-Ion Concentration; Microbial Sensitivity Tests | 1987 |
Cefpirome (HR810) disk diffusion susceptibility tests: confirmation of interpretive criteria using cefotaxime and cefoperazone-resistant strains and effects of blood supplemented media.
Topics: Bacteria; Blood; Cefoperazone; Cefotaxime; Cefpirome; Cephalosporins; Culture Media; Diffusion; Drug Resistance, Microbial; Humans; Microbial Sensitivity Tests; Species Specificity | 1986 |
Comparative in vitro activity of cefpirome and other antimicrobial agents against isolates from cancer patients.
Topics: Anti-Bacterial Agents; Bacterial Infections; Cefpirome; Cephalosporins; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Neoplasms | 1986 |
New cephalosporins cefotaxime, cefpimizole, BMY 28142, and HR 810 in experimental pneumococcal meningitis in rabbits.
Topics: Animals; Cefepime; Cefotaxime; Cefpirome; Cephalosporins; Meningitis, Pneumococcal; Rabbits; Streptococcus pneumoniae | 1985 |
HR 810 and BMY-28142, two new cephalosporins with broad-spectrum activity: an in-vitro comparison with other beta-lactam antibiotics.
Topics: Anti-Bacterial Agents; Bacteria; Cefepime; Cefpirome; Cephalosporins; Microbial Sensitivity Tests; Species Specificity | 1985 |
Comparison of in vitro activity of cefpirome with cefoperazone.
Topics: Bacterial Infections; Cefoperazone; Cefpirome; Cephalosporins; Humans | 1985 |
The antimicrobial activity of cefpirome, a new cephalosporin.
Topics: Bacteria; Bacterial Proteins; beta-Lactamases; Carrier Proteins; Cefpirome; Cephalosporins; Hexosyltransferases; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases | 1985 |
Cefpirome (HR 810): lack of selection of beta-lactamase overproducing variants.
Topics: beta-Lactamases; Cefpirome; Cephalosporins; Drug Resistance, Microbial; Enterobacter; Enterobacteriaceae; Kinetics | 1985 |
High-pressure liquid chromatographic assay and pharmacokinetics of HR 810 after intramuscular injection in rabbits.
Topics: Animals; Cefpirome; Cephalosporins; Chromatography, High Pressure Liquid; Female; Half-Life; Injections, Intramuscular; Kinetics; Rabbits; Streptococcus pyogenes | 1985 |
Evaluation of the in vitro activity of BMY-28142, a new broad-spectrum cephalosporin.
Topics: Bacteria; beta-Lactamases; Cefepime; Cefoperazone; Cefotaxime; Cefpirome; Ceftazidime; Cephalosporins; Drug Stability; Hydrolysis; Microbial Sensitivity Tests | 1985 |
Comparative in-vitro activity of Sch 34343, imipenem, cefpirome and cefotaxime.
Topics: Anti-Bacterial Agents; Bacteria; Cefotaxime; Cefpirome; Cephalosporins; Escherichia coli; Haemophilus influenzae; Imipenem; Lactams; Microbial Sensitivity Tests; Pseudomonas; Staphylococcus; Streptococcus; Thienamycins | 1985 |
Comparative in vitro inhibitory and killing activity of cefpirome, ceftazidime, and cefotaxime against Pseudomonas aeruginosa, enterococci, Staphylococcus epidermidis, and methicillin-susceptible and -resistant and tolerant and nontolerant Staphylococcus
Topics: Bacteria; Cefotaxime; Cefpirome; Ceftazidime; Cephalosporins; Enterococcus faecalis; Methicillin; Microbial Sensitivity Tests; Penicillin Resistance; Pseudomonas aeruginosa; Staphylococcus aureus; Staphylococcus epidermidis | 1985 |
[Cefpirome (HR 810). A new broad spectrum cephalosporin].
Topics: Bacteria; Cefpirome; Cephalosporins; Chemical Phenomena; Chemistry; Enterobacteriaceae; Enterococcus faecalis; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Staphylococcus aureus; Structure-Activity Relationship | 1985 |
[HR 810 (cefpirome). Experimental evaluation of the in vitro and in vivo antibiotic activity of a new amino-2-thiazole methoxy- imino cephalosporin].
Topics: Animals; Bacterial Infections; Cefpirome; Cephalosporins; Citrobacter; Enterobacter; Enterobacteriaceae; Enterococcus faecalis; Klebsiella Infections; Male; Mice; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Salmonella Infections, Animal; Salmonella typhimurium; Staphylococcal Infections; Staphylococcus aureus; Streptococcal Infections; Streptococcus pyogenes | 1985 |
Antimicrobial activity of HR810 against 419 strict anaerobic bacteria.
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Cefotaxime; Cefpirome; Cephalosporins; Drug Resistance, Microbial; Microbial Sensitivity Tests | 1985 |
In vitro activity of HR 810, a new broad-spectrum cephalosporin.
Topics: Cefotaxime; Cefpirome; Ceftazidime; Cephalosporins; Dose-Response Relationship, Drug; Enterobacteriaceae; Enterococcus faecalis; Gentamicins; Humans; Neisseriaceae; Penicillin Resistance; Piperacillin; Staphylococcus aureus | 1983 |
Relation between beta-lactamase production and antimicrobial activity: comparison of the new compound HR 810 with cefotaxime.
Topics: beta-Lactamases; Cefotaxime; Cefpirome; Cephalosporins; Enterobacteriaceae; Humans | 1983 |
HR 810, a new parenteral cephalosporin with a broad antibacterial spectrum.
Topics: Bacteria; Bacteria, Aerobic; Bacteria, Anaerobic; Cefotaxime; Cefpirome; Ceftazidime; Cephalosporins; Chemical Phenomena; Chemistry | 1983 |
Synergistic activity in vitro of the new cephalosporin antibiotic HR 810 with gentamicin and amikacin against multiresistant pathogens.
Topics: Amikacin; Anti-Bacterial Agents; Cefpirome; Cephalosporins; Drug Resistance, Microbial; Drug Synergism; Gentamicins; Kanamycin | 1984 |
Disk diffusion testing, quality control guidelines, and antimicrobial spectrum of HR810, a fourth-generation cephalosporin, in clinical microbiology laboratories.
Topics: Bacteria; Cefpirome; Cephalosporins; Enterobacteriaceae; Microbial Sensitivity Tests; Pseudomonas; Quality Control; Staphylococcus; Streptococcus | 1984 |
In vitro activity of HR 810, a new cephalosporin.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteria; Cefpirome; Cephalosporins; Imipenem; Microbial Sensitivity Tests; Thienamycins | 1984 |
HR 810, a cephalosporin with low affinity for Enterobacter cloacae beta-lactamase.
Topics: beta-Lactamases; Cefpirome; Cephalosporins; Enterobacter; Enterobacteriaceae | 1983 |
In vitro evaluation of HR810, a new wide-spectrum aminothiazolyl alpha-methoxyimino cephalosporin.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamases; Cefpirome; Cephalosporins; Enterobacteriaceae; Hydrolysis; Microbial Sensitivity Tests | 1984 |
Susceptibility of gram-positive aerobic cocci to the new cephalosporin HR 810.
Topics: Cefpirome; Cephalosporins; Drug Resistance, Microbial; Staphylococcus | 1983 |
[In vitro activity of six beta-lactams against 295 strains of enterobacteriaceae and P. aeruginosa isolated from neutropenic patients].
Topics: Cefepime; Cefotaxime; Cefpirome; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; Enterobacteriaceae; Humans; Imipenem; In Vitro Techniques; Neutropenia; Penicillanic Acid; Penicillins; Piperacillin; Pseudomonas aeruginosa; Tazobactam; Thienamycins | 1995 |
Multicentre comparative study on the antibacterial activity of FK-037, a new parenteral cephalosporin.
Topics: Aztreonam; Cefepime; Cefotaxime; Cefpirome; Ceftazidime; Ceftizoxime; Cephalosporins; Gram-Negative Bacteria; Gram-Positive Bacteria; Imipenem; Microbial Sensitivity Tests; Sensitivity and Specificity | 1995 |
[Modification of vancomycin nephrotoxicity by other antibiotics in rats].
Topics: Animals; Cefpirome; Cephalosporins; Drug Therapy, Combination; Kidney; Male; Moxalactam; Rats; Rats, Sprague-Dawley; Vancomycin | 1995 |
[Cephalosporins of the 4th generation. Further progress in antibacterial chemotherapy].
Topics: Bacterial Infections; Cefepime; Cefpirome; Cephalosporins; Gram-Negative Aerobic Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests | 1995 |
[Placental penetration of cefpirome (HR 810): study of fetal concentrations after in vitro infusions of human placenta at term].
Topics: Antipyrine; Bacterial Infections; Cefpirome; Cephalosporins; Female; Humans; Infant, Newborn; Maternal-Fetal Exchange; Pregnancy; Pregnancy Complications, Infectious | 1994 |
Failure of time-kill synergy studies using subinhibitory antimicrobial concentrations to predict in vivo antagonism of cephalosporin-rifampin combinations against Staphylococcus aureus.
Topics: Animals; Cefazolin; Cefpirome; Cephalosporins; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Endocarditis, Bacterial; Gentamicins; Microbial Sensitivity Tests; Nafcillin; Predictive Value of Tests; Rabbits; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Time Factors | 1994 |
In vitro antimicrobial activity of cefpirome against ceftazidime-resistant isolates from two multicenter studies.
Topics: Bacterial Infections; Cefpirome; Ceftazidime; Cephalosporin Resistance; Cephalosporins; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests | 1994 |
Comparative antimicrobial activity of FK037, cefpirome, ceftazidime and cefepime against aminoglycoside-sensitive and aminoglycoside-resistant Pseudomonas aeruginosa and Pseudomonas spp.
Topics: Aminoglycosides; Anti-Bacterial Agents; Cefepime; Cefpirome; Ceftazidime; Ceftizoxime; Cephalosporins; Drug Resistance, Microbial; Humans; Microbial Sensitivity Tests; Pseudomonas; Pseudomonas aeruginosa; Species Specificity | 1994 |
Conditions for the emergence of resistance to cefpirome and ceftazidime in experimental endocarditis due to Pseudomonas aeruginosa.
Topics: Animals; Cefpirome; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Endocarditis, Bacterial; Female; Microbial Sensitivity Tests; Pseudomonas Infections; Rabbits | 1994 |
Penetration of cefpirome into renal and prostatic tissue.
Topics: Cefpirome; Cephalosporins; Humans; Injections, Intravenous; Kidney; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Nephrectomy; Prostate; Prostatectomy; Tissue Distribution | 1993 |
[Diffusion of cefpirome in ascitic fluid].
Topics: Adult; Ascitic Fluid; Cefpirome; Cephalosporins; Diffusion; Female; Gram-Negative Bacterial Infections; Humans; Injections, Intravenous; Liver Cirrhosis; Male; Middle Aged | 1993 |
Canadian survey of antimicrobial resistance in Klebsiella spp. and Enterobacter spp. The Canadian Antimicrobial Resistance Study Group.
Topics: Anti-Bacterial Agents; Canada; Cefepime; Cefpirome; Cephalosporins; Drug Resistance, Microbial; Enterobacter; Enterobacteriaceae Infections; Humans; Klebsiella; Klebsiella Infections; Microbial Sensitivity Tests | 1993 |
[Antibiotic activities of cefpirome against fresh clinical isolates resistant to multiple drugs].
Topics: beta-Lactamases; Cefpirome; Cephalosporins; Drug Resistance, Microbial; Enterobacteriaceae; Enterococcus faecalis; Gram-Negative Bacteria; Gram-Positive Bacteria; Methicillin Resistance; Penicillin Resistance; Pseudomonas aeruginosa; Staphylococcus; Streptococcus pneumoniae | 1994 |
Effects of cefpirome in comparison with cefuroxime against human polymorphonuclear leucocytes in vitro.
Topics: Candida albicans; Cefpirome; Cefuroxime; Cephalosporins; Chemotaxis, Leukocyte; Humans; In Vitro Techniques; Leukocyte Adherence Inhibition Test; Neutrophils; Phagocytosis | 1994 |
Evaluation of antimicrobial regimens for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Cefpirome; Ceftriaxone; Cephalosporins; Disease Models, Animal; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Fluoroquinolones; Male; Meningitis, Pneumococcal; Meropenem; Microbial Sensitivity Tests; Penicillin Resistance; Quinolones; Rabbits; Rifampin; Thienamycins; Vancomycin | 1993 |
Single-dose pharmacokinetics of cefpirome in patients receiving hemodialysis and in patients treated by continuous ambulatory peritoneal dialysis.
Topics: Adult; Aged; Biological Availability; Cefpirome; Cephalosporins; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Models, Biological; Peritoneal Dialysis, Continuous Ambulatory; Renal Dialysis | 1993 |
The antimicrobial activity in vitro of cefpirome and 6 other beta-lactam antibacterial agents against clinical isolates.
Topics: Anti-Bacterial Agents; Bacteria; Cefpirome; Cephalosporins; Gram-Negative Bacteria; Gram-Positive Cocci; Humans; Microbial Sensitivity Tests | 1993 |
Affinity of E1077, a new cephalosporin, for penicillin-binding proteins of Staphylococcus aureus and its antistaphylococcal activity.
Topics: Autolysis; Bacterial Proteins; Carrier Proteins; Cefoxitin; Cefpirome; Cephalosporins; Hexosyltransferases; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidoglycan; Peptidyl Transferases; Staphylococcus aureus; Structure-Activity Relationship | 1993 |
Effects of beta-lactamase inducibility and derepression on the activity of cefpirome against gram-negative bacteria.
Topics: beta-Lactamases; Cefepime; Cefpirome; Cephalosporins; Enzyme Induction; Gram-Negative Bacteria; Microbial Sensitivity Tests | 1993 |
Epidemiology and sensitivity of 8625 ICU and hematology/oncology bacterial isolates in Europe. International Study Group.
Topics: Anti-Bacterial Agents; Bacterial Infections; Cefpirome; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Europe; Gram-Negative Bacteria; Gram-Positive Bacteria; Hospital Units; Humans; Intensive Care Units; Microbial Sensitivity Tests; Prevalence | 1993 |
Cross-susceptibility of cefpirome and four other beta-lactams against isolates from haematology/oncology and intensive care units. International Study Group.
Topics: Anti-Bacterial Agents; Bacterial Infections; Cefpirome; Ceftazidime; Ceftriaxone; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Europe; Gram-Negative Bacteria; Gram-Positive Bacteria; Hospital Units; Humans; Imipenem; Intensive Care Units; Microbial Sensitivity Tests; Piperacillin; Prevalence | 1993 |
The antimicrobial activity and beta-lactamase stability of cefpirome, a new fourth-generation cephalosporin in comparison with other agents.
Topics: Acinetobacter; Anti-Bacterial Agents; Bacteria; Bacteria, Anaerobic; Bacterial Infections; beta-Lactamases; Cefpirome; Cephalosporins; Citrobacter; Enterobacter; Gram-Negative Aerobic Bacteria; Gram-Positive Bacteria; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus aureus; Xanthomonas | 1993 |
Comparison of endotoxin release by different antimicrobial agents and the effect on inflammation in experimental Escherichia coli meningitis.
Topics: Animals; Anti-Bacterial Agents; Cefotaxime; Cefpirome; Cephalosporins; Chloramphenicol; Endotoxins; Escherichia coli Infections; Gentamicins; Inflammation; Male; Meningitis, Bacterial; Meropenem; Rabbits; Thienamycins | 1993 |
Effect of cephalosporins on gamma-aminobutyric acid receptor binding with or without non-steroidal anti-inflammatory drugs.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cefpirome; Cephalosporins; Convulsants; Drug Synergism; GABA-A Receptor Antagonists; In Vitro Techniques; Male; Mice | 1993 |
In vitro antibacterial activity of FK037, a novel parenteral broad-spectrum cephalosporin.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamases; Cefpirome; Ceftazidime; Ceftizoxime; Cell Membrane Permeability; Cephalosporins; Microbial Sensitivity Tests | 1993 |
FK037, a new parenteral cephalosporin with a broad antibacterial spectrum: synthesis and antibacterial activity.
Topics: Bacteria; Cefpirome; Ceftizoxime; Cephalosporins | 1993 |
The activity of cefpirome and ten other antibacterial agents against 2858 clinical isolates collected from 20 centres.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamases; Cefpirome; Cephalosporins; Drug Evaluation, Preclinical; Drug Resistance, Microbial; Enterobacteriaceae; Humans; Microbial Sensitivity Tests; Pseudomonas | 1993 |
Stability of cefpirome sulfate in the presence of commonly used intensive care drugs during simulated Y-site injection.
Topics: Amphotericin B; Antifungal Agents; Cefpirome; Cephalosporins; Chromatography, High Pressure Liquid; Critical Care; Drug Combinations; Drug Incompatibility; Drug Stability; Glucose; Injections, Intravenous; Isotonic Solutions; Ringer's Solution; Sodium Chloride; Time Factors | 1995 |
Killing activity of cefpirome against penicillin-resistant Streptococcus pneumoniae isolates from patients with meningitis in a pharmacodynamic model simulating the cerebrospinal fluid concentration profile.
Topics: Adult; Cefpirome; Ceftriaxone; Cephalosporins; Humans; Meningitis, Pneumococcal; Penicillin Resistance; Penicillins; Streptococcus pneumoniae | 1995 |
In vitro activities of cefotaxime, ceftriaxone, ceftazidime, cefpirome, and penicillin against Streptococcus pneumoniae isolates.
Topics: Cefotaxime; Cefpirome; Ceftazidime; Ceftriaxone; Cephalosporins; Microbial Sensitivity Tests; Penicillins; Streptococcus pneumoniae | 1995 |
Pharmacokinetics of cefpirome in pediatric patients.
Topics: Adolescent; Cefpirome; Cephalosporins; Child; Child, Preschool; Humans; Infant; Metabolic Clearance Rate | 1995 |
In-vitro and in-vivo antibacterial activity of LB10517, a novel catechol-substituted cephalosporin with a broad antibacterial spectrum.
Topics: Animals; beta-Lactamases; Cefpirome; Cephalosporins; Drug Resistance, Microbial; Drug Stability; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; In Vitro Techniques; Mice; Microbial Sensitivity Tests | 1996 |
[Kinetics of bactericidal activity of cefepime and cefpirome alone or combined with gentamicin, amikacin or ciprofloxacin against Acinetobacter baumannii, Stenotrophomonas maltophilia and Enterobacter cloacae hyperproductive in cephalosporinase].
Topics: Acinetobacter; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Cefepime; Cefpirome; Cephalosporinase; Cephalosporins; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enterobacter cloacae; Gentamicins; In Vitro Techniques; Xanthomonas | 1996 |
[Model of a miniature pig catheterized for pharmacokinetic and pharmacodynamic studies of anti-infective agents].
Topics: Adult; Animals; Antibiotics, Antitubercular; Antifungal Agents; Catheterization, Peripheral; Cefepime; Cefpirome; Ceftriaxone; Cephalosporins; Disease Models, Animal; Female; Humans; Injections, Intravenous; Meropenem; Swine; Thienamycins | 1996 |
[Studies on cerebrospinal fluid penetration of cefpirome in adult with meningitis].
Topics: Adult; Cefpirome; Cephalosporins; Female; Humans; Meningitis, Bacterial; Staphylococcal Infections; Time Factors | 1996 |
[Antibacterial activities of combination uses of cefpirome with various antibiotics in vitro against clinically isolated glucose non-fermentative gram-negative rods: part 1. the results against Pseudomonas aeruginosa].
Topics: Amikacin; Anti-Bacterial Agents; Aztreonam; Cefpirome; Cephalosporins; Drug Combinations; Drug Synergism; Gentamicins; Imipenem; Piperacillin; Pseudomonas aeruginosa; Tobramycin | 1996 |
[Combination effect of vancomycin and cefpirome against methicillin-resistant Staphylococcus aureus in vitro--antimicrobial activities in postantibiotic phase].
Topics: Anti-Bacterial Agents; Cefpirome; Cephalosporins; Drug Synergism; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus aureus; Vancomycin | 1996 |
In vitro susceptibilities of Bordetella pertussis and Bordetella parapertussis to four fluoroquinolones (levofloxacin, d-ofloxacin, ofloxacin, and ciprofloxacin), cefpirome, and meropenem.
Topics: Anti-Infective Agents; Bordetella; Bordetella Infections; Bordetella pertussis; Cefpirome; Cephalosporins; Fluoroquinolones; Humans; Meropenem; Microbial Sensitivity Tests; Thienamycins; Whooping Cough | 1996 |
Influence of experimental rat model of multiple organ dysfunction on cefepime and amikacin pharmacokinetics.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Cefpirome; Cephalosporins; Half-Life; Lung; Multiple Organ Failure; Rats | 1996 |
Antipneumococcal activities of cefpirome and cefotaxime, alone and in combination with vancomycin and teicoplanin, determined by checkerboard and time-kill methods.
Topics: Anti-Bacterial Agents; Cefotaxime; Cefpirome; Cephalosporins; Drug Synergism; Drug Therapy, Combination; Microbial Sensitivity Tests; Penicillin Resistance; Streptococcus pneumoniae; Teicoplanin; Time Factors; Vancomycin | 1996 |
In vitro activity of cefpirome versus five other cephalosporins against clinical isolates.
Topics: Bacteria; Cefpirome; Cephalosporins; Humans; Microbial Sensitivity Tests | 1995 |
[Synergic effect of a teicoplanin and cefpirome combination with aminoglucosides on enterococci. Therapeutic importance].
Topics: Aminoglycosides; Anti-Bacterial Agents; Cefpirome; Cephalosporins; Drug Therapy, Combination; Enterococcus; Humans; Microbial Sensitivity Tests; Teicoplanin | 1995 |
Synergy between aminoglycosides and penicillin, teicoplanin and cefpirome in enterococci.
Topics: Aminoglycosides; Anti-Bacterial Agents; Cefpirome; Cephalosporins; Drug Synergism; Enterococcus; Penicillins; Teicoplanin | 1996 |
Spinal epidural abscess associated with epidural anesthesia: gadolinium-enhanced magnetic resonance imaging and its usefulness in diagnosis and treatment.
Topics: Abscess; Adult; Ampicillin; Anesthesia, Epidural; Cefpirome; Cephalosporins; Drug Therapy, Combination; Epidural Space; Gadolinium; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Spinal Diseases | 1996 |
Multiple-dose pharmacokinetics of cefpirome in long-term hemodialysis with high-flux membranes.
Topics: Adult; Aged; Cefpirome; Cephalosporins; Chromatography, High Pressure Liquid; Female; Humans; Infusions, Intravenous; Kidney Failure, Chronic; Male; Membranes, Artificial; Middle Aged; Polymers; Renal Dialysis; Sulfones | 1996 |
In-vitro bactericidal activity of cefpirome in combination with vancomycin against Staphylococcus aureus and coagulase-negative staphylococci.
Topics: Anti-Bacterial Agents; Cefpirome; Cephalosporins; Coagulase; Drug Therapy, Combination; Kinetics; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus; Staphylococcus aureus; Vancomycin | 1996 |
Positive interference with the Jaffé reaction by cefpirome.
Topics: Cefpirome; Cephalosporins; Creatinine; Drug Interactions; Humans; Picrates; Pneumonia; Urea | 1997 |
Treatment of experimental pneumonia due to penicillin-resistant Streptococcus pneumoniae in immunocompetent rats.
Topics: Animals; Anti-Bacterial Agents; Cefotaxime; Cefpirome; Cephalosporins; Culture Media; Half-Life; Lung; Male; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Pneumonia, Pneumococcal; Rats; Rats, Wistar; Streptococcus pneumoniae; Vancomycin | 1997 |
Application of capillary zone electrophoresis in cephalosporin analysis.
Topics: Cefotaxime; Cefpirome; Cefuroxime; Cephalosporins; Electrophoresis, Capillary; Hydrogen-Ion Concentration | 1997 |
[Results of a "round table" on cefpirome (Keiten)].
Topics: Bacterial Infections; Cefpirome; Cephalosporins; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans | 1996 |
[A new fourth generation cephalosporin antibiotic--cefpirome].
Topics: Cefpirome; Cephalosporins; Enterobacteriaceae; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 1996 |
[Characterization of antimicrobial properties of cefpirome].
Topics: beta-Lactam Resistance; beta-Lactamases; Cefpirome; Cell Membrane Permeability; Cephalosporins; Chromosomes, Bacterial; Drug Evaluation, Preclinical; Gram-Negative Bacteria; Microbial Sensitivity Tests; Staphylococcus | 1996 |
[A case of red blood cell(RBC) agglutination on peripheral blood smear and effect of cefpirom sulfate].
Topics: Cefpirome; Cells, Cultured; Cephalosporins; Child, Preschool; Dose-Response Relationship, Drug; Erythrocyte Aggregation; Humans; Male; Temperature | 1997 |
Comparative in vitro susceptibility of Burkholderia Pseudomallei to cefpirome, ceftazidime and cefepime.
Topics: Burkholderia pseudomallei; Cefepime; Cefpirome; Ceftazidime; Cephalosporins; Microbial Sensitivity Tests | 1997 |
[In vivo pharmacokinetic of amikacin and its pharmacodynamic in combination with cefepime, cefpirome and meropenem in an in vitro/ex vivo micropig model].
Topics: Amikacin; Animals; Anti-Bacterial Agents; Cefepime; Cefpirome; Cephalosporins; Disease Models, Animal; Drug Therapy, Combination; Female; Humans; In Vitro Techniques; Klebsiella pneumoniae; Meropenem; Perfusion; Serum Bactericidal Test; Swine; Thienamycins | 1997 |
[Evaluation of bactericidal activity of cefpirome-aminoglycoside combination against Pseudomonas aeruginosa strains with intermediate sensitivity to cefpirome and in various phenotypes of beta-lactam resistance].
Topics: Amikacin; Anti-Bacterial Agents; Cefpirome; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; In Vitro Techniques; Microbial Sensitivity Tests; Phenotype; Pseudomonas aeruginosa; Tobramycin | 1997 |
Susceptibilities of Chryseobacterium indologenes and Chryseobacterium meningosepticum to cefepime and cefpirome.
Topics: Cefepime; Cefpirome; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Flavobacterium; Gram-Negative Bacterial Infections; Humans; In Vitro Techniques; Microbial Sensitivity Tests | 1997 |
Sporadic emergence of Klebsiella pneumoniae strains resistant to cefepime and cefpirome in Greek hospitals.
Topics: Cefepime; Cefpirome; Cephalosporins; Drug Resistance, Microbial; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests | 1998 |
Concentrations of cefpirome in cerebrospinal fluid of children with bacterial meningitis after a single intravenous dose.
Topics: Cefpirome; Cephalosporins; Child; Child, Preschool; Female; Humans; Infant; Injections, Intravenous; Male; Meningitis, Bacterial | 1998 |
[Effectiveness of cefpirome on Klebsiella pneumoniae producing beta-lactamases with an extended spectrum of activity].
Topics: beta-Lactamases; Cefpirome; Cephalosporins; Klebsiella pneumoniae; Microbial Sensitivity Tests | 1998 |
Determination of activities of levofloxacin, alone and combined with gentamicin, ceftazidime, cefpirome, and meropenem, against 124 strains of Pseudomonas aeruginosa by checkerboard and time-kill methodology.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cefpirome; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Gentamicins; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Ofloxacin; Pseudomonas aeruginosa; Thienamycins; Time Factors | 1998 |
In vitro activity of cefpirome against microorganisms isolated in haematology, oncology and intensive care units in Switzerland.
Topics: Anti-Bacterial Agents; Bacteria; Cefpirome; Cephalosporinase; Cephalosporins; Drug Resistance, Microbial; Hospital Units; Humans; Intensive Care Units; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus; Switzerland | 1997 |
In-vitro activity of 21 beta-lactam antibiotics against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae.
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cefaclor; Cefadroxil; Cefatrizine; Cefepime; Cefixime; Cefotaxime; Cefpirome; Cefpodoxime; Ceftazidime; Ceftibuten; Ceftizoxime; Ceftriaxone; Cefuroxime; Cephalosporins; Cephradine; Drug Resistance, Microbial; Drug Resistance, Multiple; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Piperacillin; Pneumococcal Infections; Serotyping; Species Specificity; Streptococcus pneumoniae | 1998 |
Comparative in-vitro activity of cefpirome against isolates from intensive care and haematology/oncology units. Belgian Multicentre Study Group.
Topics: beta-Lactam Resistance; Cefepime; Cefpirome; Cephalosporins; Drug Resistance, Microbial; Enterobacteriaceae; Gram-Negative Bacteria; Gram-Positive Cocci; Hematology; Hospital Units; Humans; Intensive Care Units; Microbial Sensitivity Tests; Oncology Service, Hospital | 1998 |
Prospective study of bacteraemia in cancer patients. Results of a French multicentre study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacteremia; Bacteria; Bacteriological Techniques; Cefepime; Cefpirome; Ceftazidime; Cephalosporins; Child; Child, Preschool; Female; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Neoplasms; Opportunistic Infections; Prospective Studies | 1998 |
In vitro bactericidal activity of cefpirome in combination with vancomycin against Staphylococcus aureus and coagulase-negative Staphylococcus.
Topics: Anti-Bacterial Agents; Cefpirome; Cephalosporins; Coagulase; Drug Interactions; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Staphylococcus; Staphylococcus aureus; Vancomycin | 1998 |
In vitro activities of six extended spectrum beta-lactam antibiotics against clinically significant gram-negative bacteria.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Cefepime; Cefpirome; Cephalosporins; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests | 1998 |
Cefpirome: epidemiological survey in intensive care units and hematological units in The Netherlands. The Dutch Study Group.
Topics: Bacterial Infections; Cefpirome; Cephalosporins; Cross Infection; Data Collection; Gram-Negative Bacteria; Gram-Positive Bacteria; Hematology; Hospital Units; Humans; Intensive Care Units; Microbial Sensitivity Tests; Netherlands; Species Specificity | 1998 |
In vitro evaluation of cefpirome: an Australasian study of isolates from intensive care unit and hematology/oncology patients. The Cefpirome Study Group.
Topics: Australia; Bacterial Infections; Cefpirome; Cephalosporins; Drug Resistance, Microbial; Gram-Negative Bacteria; Gram-Positive Bacteria; Hematologic Neoplasms; Hospital Units; Humans; Intensive Care Units; Microbial Sensitivity Tests | 1998 |
In vitro activity of cefpirome against Streptococcus pneumoniae strains with decreased susceptibility to cefotaxime.
Topics: Cefotaxime; Cefpirome; Cephalosporins; Drug Resistance, Microbial; Humans; Microbial Sensitivity Tests; Species Specificity; Streptococcus pneumoniae | 1998 |
A rapid high-performance liquid chromatographic assay for cefepime, cefpirome and meropenem.
Topics: Cefepime; Cefpirome; Cephalosporins; Chromatography, High Pressure Liquid; Humans; Meropenem; Thienamycins | 1998 |
[Comparative study of the bactericidal activity of cefepime and cefpirome in association with glycopeptides against Staphylococci sensitive and resistant to methicillin].
Topics: Anti-Bacterial Agents; Cefepime; Cefpirome; Cephalosporins; Drug Therapy, Combination; Glycopeptides; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus | 1998 |
Use of in vitro models of haemofiltration and haemodiafiltration to estimate dosage regimens for critically ill patients prescribed cefpirome.
Topics: Cefpirome; Cephalosporins; Chromatography, High Pressure Liquid; Critical Illness; Hemodiafiltration; Hemofiltration; Humans; In Vitro Techniques; Membranes, Artificial; Models, Biological; Renal Replacement Therapy | 1998 |
Study of the pharmacokinetics of cefpirome sulphate in the elderly.
Topics: Aged; Area Under Curve; Cefpirome; Cephalosporins; Creatinine; Female; Half-Life; Humans; Infusions, Intravenous; Male; Urinary Tract Infections | 1998 |
Pharmacokinetics of cefpirome during the posttraumatic systemic inflammatory response syndrome.
Topics: Adult; Anti-Infective Agents; Case-Control Studies; Cefpirome; Cephalosporins; Ciprofloxacin; Drug Therapy, Combination; Humans; Infusions, Intravenous; Least-Squares Analysis; Male; Metabolic Clearance Rate; Middle Aged; Prospective Studies; Statistics, Nonparametric; Systemic Inflammatory Response Syndrome; Wounds and Injuries | 1999 |
In vivo and in vitro positive interference by cefpirome in measurement of serum creatinine by the Jaffe method.
Topics: Aged; Aged, 80 and over; Artifacts; Cefpirome; Cephalosporins; Creatinine; Female; Humans; Predictive Value of Tests | 1999 |
In vitro and in vivo activities of Syn2190, a novel beta-lactamase inhibitor.
Topics: Animals; beta-Lactamase Inhibitors; beta-Lactamases; Cefpirome; Ceftazidime; Cephalosporins; Citrobacter freundii; Drug Synergism; Enterobacter cloacae; Enterobacteriaceae; Enzyme Induction; Enzyme Inhibitors; Female; Male; Mice; Microbial Sensitivity Tests; Monobactams; Penicillanic Acid; Pseudomonas aeruginosa; Tazobactam | 1999 |
Combination antimicrobial therapy of acute Burkholderia pseudomallei infection in a mouse model.
Topics: Animals; Burkholderia pseudomallei; Cefpirome; Ceftazidime; Cephalosporins; Chloramphenicol; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Therapy, Combination; Liver; Melioidosis; Mice; Mice, Inbred BALB C; Spleen; Trimethoprim, Sulfamethoxazole Drug Combination | 1999 |
Antimicrobial susceptibility patterns of enterococci causing infections in Europe. The European VRE Study Group.
Topics: Anti-Bacterial Agents; Carbapenems; Cefpirome; Cephalosporins; Chloramphenicol; Enterococcus faecalis; Enterococcus faecium; Europe; Fluoroquinolones; Glycopeptides; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Penicillins | 1999 |
Determination of cefepime and cefpirome in human serum by high-performance liquid chromatography using an ultrafiltration for antibiotics serum extraction.
Topics: Cefepime; Cefpirome; Cephalosporins; Chromatography, High Pressure Liquid; Drug Monitoring; Humans; Quality Control; Sensitivity and Specificity; Ultrafiltration | 1999 |
Pharmacokinetics of cefpirome in critically ill patients with renal failure treated by continuous veno-venous hemofiltration.
Topics: Aged; APACHE; Cefpirome; Cephalosporins; Critical Care; Female; Hemofiltration; Humans; Infusions, Intravenous; Male; Middle Aged; Multiple Organ Failure; Renal Insufficiency; Sepsis; Serum Bactericidal Test | 1999 |
Imipenem resistance of enterobacter aerogenes mediated by outer membrane permeability.
Topics: Bacterial Typing Techniques; beta-Lactamases; Cefpirome; Cell Membrane Permeability; Cephalosporins; Drug Resistance, Microbial; Enterobacter; Enterobacteriaceae Infections; Fatal Outcome; France; Humans; Imipenem; Male; Microbial Sensitivity Tests; Thienamycins; Trachea; Urine | 2000 |
In-vitro activity of FK 037 (Cefoselis), a novel 4(th) generation cephalosporin, compared to cefepime and cefpirome on nosocomial staphylococci and gram-negative isolates.
Topics: Acinetobacter; Cefepime; Cefpirome; Ceftizoxime; Cephalosporins; Cross Infection; Enterobacteriaceae; Gram-Negative Bacteria; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Pseudomonas; Staphylococcus aureus; Stenotrophomonas | 2000 |
Pharmacokinetics of cefpirome during continuous venovenous hemofiltration: rationale for an 8-hour dosing interval.
Topics: Acute Kidney Injury; Anuria; Area Under Curve; Cefpirome; Cephalosporins; Chromatography, High Pressure Liquid; Female; Half-Life; Hemofiltration; Humans; Intensive Care Units; Male; Metabolic Clearance Rate; Middle Aged | 2000 |
Micellar electrokinetic chromatography for the analysis of cefpirome in microdialysis and plasma samples obtained in vivo from human volunteers.
Topics: Adsorption; Blood Proteins; Cefpirome; Cephalosporins; Chromatography, Micellar Electrokinetic Capillary; Extracellular Space; Humans; Microdialysis; Protein Binding; Ultracentrifugation; Volunteers | 2000 |
Cefpirome and continuous venovenous hemofiltration.
Topics: Cefpirome; Cephalosporins; Cross Infection; Hemofiltration; Humans | 2000 |
Cefpirome and continuous venovenous hemofiltration.
Topics: Cefpirome; Cephalosporins; Hemofiltration; Humans; Systemic Inflammatory Response Syndrome | 2000 |
[Antibiotic sensitivity of enterobacteria in intensive care units].
Topics: Ascitic Fluid; Blood; Catheterization; Cefepime; Cefotaxime; Cefpirome; Ceftazidime; Cephalosporin Resistance; Cephalosporins; Drug Resistance, Microbial; Enterobacteriaceae; France; Humans; Intensive Care Units; Microbial Sensitivity Tests; Respiratory System; Urine | 2000 |
In-vitro antimicrobial activity of Cefpirome: a new fourth-generation cephalosporin against clinically significant bacteria.
Topics: Bacteria; Cefpirome; Cephalosporins; Humans; Microbial Sensitivity Tests | 2000 |
CP6679, a new injectable cephalosporin. Part 1: synthesis and structure-activity relationships.
Topics: Cefpirome; Ceftazidime; Cephalosporins; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Injections; Methicillin Resistance; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Staphylococcus aureus; Structure-Activity Relationship | 2000 |
Extension of resistance to cefepime and cefpirome associated to a six amino acid deletion in the H-10 helix of the cephalosporinase of an Enterobacter cloacae clinical isolate.
Topics: Amino Acid Sequence; Bacterial Proteins; Base Sequence; beta-Lactamases; Cefepime; Cefpirome; Cephalosporin Resistance; Cephalosporinase; Cephalosporins; Child; Cloning, Molecular; Enterobacter cloacae; Enterobacteriaceae Infections; Escherichia coli; Genes, Bacterial; Humans; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Protein Structure, Secondary; Recombinant Proteins; Sequence Deletion | 2001 |
In-vitro bactericidal activity of cefpirome and cefamandole in combination with glycopeptides against methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Cefamandole; Cefpirome; Cephalosporins; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Methicillin Resistance; Microbial Sensitivity Tests; Serum Bactericidal Test; Staphylococcus aureus; Teicoplanin; Vancomycin | 1999 |
Low cefpirome levels during twice daily dosing in critically ill septic patients: pharmacokinetic modelling calls for more frequent dosing.
Topics: Adult; Aged; APACHE; Area Under Curve; Cefpirome; Cephalosporins; Critical Illness; Female; Half-Life; Humans; Infusions, Intravenous; Intensive Care Units; Male; Middle Aged; Prospective Studies; Sepsis; Treatment Outcome | 2001 |
In vitro activity of cefpirome and vancomycin in combination against gentamicin-susceptible and gentamicin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Cefpirome; Cephalosporins; Colony Count, Microbial; Drug Resistance, Microbial; Drug Therapy, Combination; Gentamicins; Humans; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2001 |
[Clinical investigation of cefpirome for perinatal infection and infection prevention].
Topics: Adult; Cefpirome; Cephalosporins; Cesarean Section; Chorioamnionitis; Female; Humans; Infusions, Intravenous; Postoperative Complications; Pregnancy; Puerperal Infection; Safety; Uterine Diseases | 2001 |
Mutation in Serratia marcescens AmpC beta-lactamase producing high-level resistance to ceftazidime and cefpirome.
Topics: Amino Acid Sequence; Bacterial Proteins; beta-Lactamases; Cefpirome; Ceftazidime; Cell Membrane Permeability; Cephalosporins; DNA Primers; Drug Resistance, Microbial; Electrophoresis, Polyacrylamide Gel; Isoelectric Focusing; Molecular Sequence Data; Mutation; Phenotype; Polymerase Chain Reaction; Sequence Homology, Amino Acid; Serratia marcescens; Transfection | 2001 |
Staphylococcal scalded skin syndrome developing during burn treatment.
Topics: Arm; Back; Burns; Cefpirome; Cephalosporins; Child, Preschool; Diagnosis, Differential; Female; Humans; Iatrogenic Disease; Staphylococcal Scalded Skin Syndrome | 2001 |
Effect of inoculum size on the antibacterial activity of cefpirome and cefepime against Klebsiella pneumoniae strains producing SHV extended-spectrum beta-lactamases.
Topics: beta-Lactamases; Cefepime; Cefpirome; Cephalosporins; Colony Count, Microbial; Drug Resistance, Bacterial; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2001 |
Plasma and tissue pharmacokinetics of cefpirome in patients with sepsis.
Topics: Aged; Aged, 80 and over; Cefpirome; Cephalosporins; Female; Humans; Male; Middle Aged; Prospective Studies; Sepsis; Tissue Distribution | 2002 |
Antimicrobial susceptibility of major pathogens of orofacial odontogenic infections to 11 beta-lactam antibiotics.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Bacteroidaceae Infections; beta-Lactams; Cefepime; Cefmetazole; Cefoperazone; Cefpirome; Ceftazidime; Ceftizoxime; Cephalosporins; Drug Resistance, Bacterial; Drug Therapy, Combination; Fusobacterium; Fusobacterium Infections; Gram-Positive Bacterial Infections; Humans; Imipenem; Lactams; Microbial Sensitivity Tests; Mouth Diseases; Penicillin G; Penicillins; Peptostreptococcus; Porphyromonas gingivalis; Prevotella; Streptococcal Infections; Streptococcus; Sulbactam | 2002 |
Determination of the dissociation constants of the cephalosporins cefepime and cefpirome using UV spectrometry and pH potentiometry.
Topics: Cefepime; Cefpirome; Cephalosporins; Hydrogen-Ion Concentration; Potentiometry; Spectrophotometry, Ultraviolet | 2003 |
Target site bacterial killing of cefpirome and fosfomycin in critically ill patients.
Topics: Anti-Bacterial Agents; Cefpirome; Cephalosporins; Colony Count, Microbial; Drug Therapy, Combination; Fosfomycin; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Shock, Septic; Staphylococcus aureus | 2003 |
Post-exposure effects of cefepime and cefpirome on isogenic Escherichia coli hosts producing SHV-extended-spectrum beta-lactamases.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cefepime; Cefpirome; Cephalosporins; Colony Count, Microbial; Drug Resistance, Bacterial; Escherichia coli; Humans; Microbial Sensitivity Tests | 2003 |
[Pharmacokinetics of antibiotics in inflamed and healthy lung tissue].
Topics: Anti-Bacterial Agents; Cefpirome; Cephalosporins; Empyema, Pleural; Extracellular Space; Humans; Lung; Microbial Sensitivity Tests; Microdialysis; Penicillanic Acid; Piperacillin; Pneumonia, Bacterial; Tazobactam; Thoracotomy | 2003 |
[Yearly changes in antibacterial activities of cefozopran against various clinical isolates between 1996 and 2001--II. Gram-negative bacteria].
Topics: Cefepime; Cefoperazone; Cefozopran; Cefpirome; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli; Gram-Negative Bacteria; Humans; Moraxella | 2003 |
In-vitro and in-vivo studies of cefpirom using bile salts as absorption enhancers.
Topics: Animals; Area Under Curve; Bile Acids and Salts; Biological Availability; Biological Transport; Cefpirome; Cell Membrane Permeability; Cephalosporins; Chromatography, High Pressure Liquid; Female; Glucose; Intestinal Absorption; Models, Biological; Rabbits | 2003 |
[The trend and susceptibility to antibacterial agents of enterococcus species from urinary tract infections].
Topics: Ampicillin Resistance; Anti-Bacterial Agents; Cefozopran; Cefpirome; Cephalosporins; Cilastatin; Drug Resistance, Bacterial; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Humans; Imipenem; Microbial Sensitivity Tests; Urinary Tract Infections | 2004 |
Resistance to cefepime and cefpirome due to a 4-amino-acid deletion in the chromosome-encoded AmpC beta-lactamase of a Serratia marcescens clinical isolate.
Topics: Amino Acid Sequence; Bacterial Proteins; beta-Lactamases; Cefepime; Cefpirome; Cephalosporin Resistance; Cephalosporinase; Cephalosporins; Chromosomes, Bacterial; Electrophoresis, Polyacrylamide Gel; Escherichia coli; Hydrolysis; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Plasmids; Sequence Deletion; Serratia Infections; Serratia marcescens | 2004 |
Resistance to imipenem, cefepime, and cefpirome associated with mutation in Omp36 osmoporin of Enterobacter aerogenes.
Topics: Bacterial Outer Membrane Proteins; Base Sequence; Cefepime; Cefpirome; Cephalosporins; DNA Primers; Drug Resistance, Microbial; Enterobacter aerogenes; Imipenem; Mutation | 2004 |
In vitro combined bactericidal activity of cefpirome and glycopeptides against glycopeptides and oxacillin-resistant staphylococci.
Topics: Anti-Bacterial Agents; Cefpirome; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Glycopeptides; Humans; In Vitro Techniques; Oxacillin; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis; Staphylococcus haemolyticus | 2004 |
In vitro activity of cefepime and cefpirome compared to other third-generation cephem antibiotics against gram-negative nosocomial pathogens.
Topics: Cefepime; Cefpirome; Cephalosporins; Cross Infection; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Microbial Sensitivity Tests | 2004 |
Pharmacokinetics and pharmacodynamics of cefpirome in subcutaneous adipose tissue of septic patients.
Topics: Adipose Tissue; Adult; Area Under Curve; Cefpirome; Cephalosporins; Chromatography, Micellar Electrokinetic Capillary; Colony Count, Microbial; Female; Humans; Male; Microbial Sensitivity Tests; Microdialysis; Pseudomonas aeruginosa; Sepsis; Staphylococcus aureus | 2005 |
[Treatment with cefrom (cefpirom) in severe urological infections].
Topics: Adolescent; Adult; Anti-Bacterial Agents; Cefpirome; Cephalosporins; Drug Administration Schedule; Humans; Middle Aged; Treatment Outcome; Urinary Tract Infections; Urine | 2004 |
[Application of four variants of the diagnostic disc test (CD01, CD02, CD03, CD04) for detection of ESBL-positive strains of gram-negative rods].
Topics: Anti-Bacterial Agents; beta-Lactamases; Cefpirome; Cephalosporins; Clavulanic Acids; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Microbial Sensitivity Tests | 2005 |
An epidemiological study of three cephalosporins: cefotetan, cefixime and cefpirome.
Topics: Bacteria; Bacterial Infections; Cefixime; Cefotetan; Cefpirome; Cephalosporins; Humans; Microbial Sensitivity Tests; Regression Analysis | 1989 |
Influence of absorption enhancers on the pharmacokinetic properties of non-oral beta-lactam-cefpirom using the rabbit (Chinchilla) in vivo model.
Topics: Animals; Anti-Bacterial Agents; Biological Availability; Cefpirome; Cell Membrane Permeability; Cephalosporins; Dodecanol; Fatty Alcohols; Female; Injections, Intravenous; Intestinal Absorption; Intubation, Gastrointestinal; Membranes, Artificial; Quaternary Ammonium Compounds; Rabbits; Salicylates | 2006 |
Application of the ion pair concept to the n-octanol-water partitioning of cefepime and cefpirome.
Topics: 1-Octanol; Anti-Bacterial Agents; Cefepime; Cefpirome; Cephalosporins; Chromatography, High Pressure Liquid; Hydrogen-Ion Concentration; Ions; Models, Chemical; Molecular Structure; Water | 2006 |
A rp-HPLC method for the assay of cefpirome and its application in drug-metal interaction studies.
Topics: Anti-Bacterial Agents; Cefpirome; Cephalosporins; Chromatography, High Pressure Liquid; Drug Interactions; Metals | 2006 |
[High effectiveness of the method with cefpirome in detection of extended-spectrum beta-lactamases in different species of gram-negative bacilli].
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; Bacteriological Techniques; beta-Lactam Resistance; beta-Lactamases; Cefotaxime; Cefpirome; Cephalosporins; Clavulanic Acid; Gram-Negative Bacteria; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Species Specificity | 2006 |
[Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2004). I. Susceptibility distribution].
Topics: Aminoglycosides; Ampicillin; Anti-Infective Agents; Aztreonam; Cefixime; Cefozopran; Cefpirome; Cefpodoxime; Ceftizoxime; Cephalosporins; Dibekacin; Drug Resistance, Bacterial; Enterococcus faecalis; Escherichia coli; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Proteus mirabilis; Pseudomonas aeruginosa; Quinolones; Serratia marcescens; Staphylococcus aureus; Thienamycins; Urinary Tract Infections; Vancomycin | 2006 |
Disposition kinetics and urinary excretion of cefpirome after intravenous injection in buffalo calves.
Topics: Animals; Buffaloes; Cefpirome; Cephalosporins; Injections, Intravenous; Kinetics; Metabolic Clearance Rate | 2007 |
Population pharmacokinetics and pharmacodynamics of cefpirome in critically ill patients against Gram-negative bacteria.
Topics: Adult; Aged; Anti-Bacterial Agents; Cefpirome; Cephalosporins; Creatinine; Critical Illness; Dose-Response Relationship, Drug; Female; Gram-Negative Bacterial Infections; Humans; Infusions, Intravenous; Intensive Care Units; Male; Metabolic Clearance Rate; Middle Aged; Models, Biological; Monte Carlo Method | 2007 |
In vitro activity of cefadroxil, cephalexin, cefatrizine and cefpirome in presence of essential and trace elements.
Topics: Anti-Bacterial Agents; Cefadroxil; Cefatrizine; Cefpirome; Cephalexin; Cephalosporins; Colony Count, Microbial; Gram-Negative Bacteria; Gram-Positive Bacteria; Metals; Microbial Sensitivity Tests; Salts; Trace Elements | 2007 |
Emergence of a cefepime- and cefpirome-resistant Citrobacter freundii clinical isolate harbouring a novel chromosomally encoded AmpC beta-lactamase, CMY-37.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Cefepime; Cefpirome; Cephalosporin Resistance; Cephalosporins; Chromosomes, Bacterial; Citrobacter freundii; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Phylogeny | 2008 |
Daptomycin elimination by CVVH in vitro: evaluation of factors influencing sieving and membrane adsorption.
Topics: Adsorption; Anti-Bacterial Agents; Cefpirome; Cephalosporins; Chromatography, High Pressure Liquid; Daptomycin; Dose-Response Relationship, Drug; Hemofiltration; Humans; In Vitro Techniques; Membranes, Artificial; Metabolic Clearance Rate; Models, Biological; Rheology | 2009 |
Microemulsion and mixed micelle for oral administration as new drug formulations for highly hydrophilic drugs.
Topics: Administration, Oral; Animals; Biological Availability; Cefotaxime; Cefpirome; Cephalosporins; Drug Carriers; Drug Compounding; Emulsions; Female; Intestinal Absorption; Micelles; Rabbits | 2010 |
Tigecycline resistance in Serratia marcescens associated with up-regulation of the SdeXY-HasF efflux system also active against ciprofloxacin and cefpirome.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Biological Transport, Active; Cefpirome; Cephalosporins; Ciprofloxacin; Drug Resistance, Bacterial; Gene Deletion; Humans; Membrane Transport Proteins; Microbial Sensitivity Tests; Minocycline; Mutation; Reverse Transcriptase Polymerase Chain Reaction; Selection, Genetic; Serratia Infections; Serratia marcescens; Tigecycline; Up-Regulation | 2010 |
Assessment of oritavancin serum protein binding across species.
Topics: Animals; Anti-Bacterial Agents; Blood Proteins; Cefpirome; Cephalosporins; Daptomycin; Dogs; Glycopeptides; Humans; Lipoglycopeptides; Mice; Microbial Sensitivity Tests; Protein Binding; Rats; Species Specificity; Staphylococcus aureus | 2010 |
Development of an analytical method for cefpirome in plasma by simplified HPLC technique and its applications.
Topics: Animals; Anti-Bacterial Agents; Cefpirome; Cephalosporins; Chromatography, High Pressure Liquid; Humans; Injections, Intravenous; Rabbits; Reproducibility of Results | 2010 |
High extracellular levels of cefpirome in unaffected and infected lung tissue of patients.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefpirome; Cephalosporins; Female; Humans; Injections, Intravenous; Lung; Male; Middle Aged; Time Factors | 2011 |
Comparable population pharmacokinetics and pharmacodynamic breakpoints of cefpirome in cystic fibrosis patients and healthy volunteers.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Body Size; Cefpirome; Cephalosporins; Cystic Fibrosis; Female; Humans; Male; Microbial Sensitivity Tests; Monte Carlo Method | 2011 |
Voltammetric determination of cefpirome at multiwalled carbon nanotube modified glassy carbon sensor based electrode in bulk form and pharmaceutical formulation.
Topics: Anti-Bacterial Agents; Calibration; Cefpirome; Cephalosporins; Chemistry, Pharmaceutical; Electrochemistry; Electrodes; Glass; Limit of Detection; Nanotubes, Carbon; Pharmaceutical Preparations; Potentiometry; Sensitivity and Specificity | 2011 |
False extended-spectrum {beta}-lactamase phenotype in clinical isolates of Escherichia coli associated with increased expression of OXA-1 or TEM-1 penicillinases and loss of porins.
Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; beta-Lactamases; Cefepime; Cefpirome; Cephalosporins; Clavulanic Acid; DNA; DNA, Recombinant; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enzyme Inhibitors; Escherichia coli; Escherichia coli Infections; Isoelectric Focusing; Microbial Sensitivity Tests; Plasmids; Porins; Reverse Transcriptase Polymerase Chain Reaction; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Transformation, Bacterial | 2011 |
BioDMET: a physiologically based pharmacokinetic simulation tool for assessing proposed solutions to complex biological problems.
Topics: Algorithms; Animal Structures; Animals; Biological Transport; Biotransformation; Body Fluids; Cefotaxime; Cefpirome; Cephalosporins; Computer Simulation; Contrast Media; Databases, Factual; Eukaryotic Cells; Guinea Pigs; Haplorhini; Humans; Internet; Iohexol; Mice; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Rats; Reproducibility of Results; Software; Tissue Distribution; User-Computer Interface | 2012 |
Abscess penetration of cefpirome: concentrations and simulated pharmacokinetic profiles in pus.
Topics: Abscess; Anti-Bacterial Agents; Area Under Curve; Body Fluids; Cefpirome; Cephalosporins; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Models, Biological; Suppuration | 2012 |
Molecular dynamics and molecular docking studies on E166A point mutant, R274N/R276N double mutant, and E166A/R274N/R276N triple mutant forms of class A β-lactamases.
Topics: Alanine; Anti-Bacterial Agents; Asparagine; beta-Lactamases; Cefpirome; Cephalosporins; Humans; Hydrogen Bonding; Ligands; Molecular Docking Simulation; Molecular Dynamics Simulation; Mutation | 2014 |
Stability studies of cefpirome sulfate in the solid state: Identification of degradation products.
Topics: Cefpirome; Cephalosporins; Chromatography, High Pressure Liquid; Drug Stability; Humidity; Kinetics; Mass Spectrometry; Temperature; Thermodynamics | 2014 |
Investigation of interaction studies of cefpirome with ACE-inhibitors in various buffers.
Topics: Angiotensin-Converting Enzyme Inhibitors; Buffers; Cefpirome; Cephalosporins; Chromatography, High Pressure Liquid; Chromatography, Reverse-Phase; Hydrogen-Ion Concentration; Magnetic Resonance Spectroscopy; Spectroscopy, Fourier Transform Infrared | 2015 |
In vitro bactericidal activity of cefepime and cefpirome against clinical isolates at Karachi.
Topics: Anti-Bacterial Agents; Bacteremia; Cefepime; Cefpirome; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; In Vitro Techniques; Intraabdominal Infections; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Pakistan; Proteus; Proteus Infections; Respiratory Tract Infections; Skin Diseases, Bacterial; Soft Tissue Infections; Staphylococcal Infections; Staphylococcus aureus; Urinary Tract Infections | 2015 |
Stability studies of cefoselis sulfate in the solid state.
Topics: Air; Catalysis; Cefozopran; Cefpirome; Ceftizoxime; Cephalosporins; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Drug Stability; Humidity; Kinetics; Sulfates; Tandem Mass Spectrometry; Temperature; Thermodynamics | 2015 |
Investigation on the interaction of cefpirome sulfate with lysozyme by fluorescence quenching spectroscopy and synchronous fluorescence spectroscopy.
Topics: Binding Sites; Cefpirome; Cephalosporins; Molecular Conformation; Muramidase; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet; Temperature | 2016 |
The radiolytic studies of cefpirome sulfate in the solid state.
Topics: Anti-Bacterial Agents; Cefpirome; Cell Line; Cell Survival; Cephalosporins; Chromatography, High Pressure Liquid; Electron Spin Resonance Spectroscopy; Humans; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis, Raman | 2016 |
The biodegradation of cefuroxime, cefotaxime and cefpirome by the synthetic consortium with probiotic Bacillus clausii and investigation of their potential biodegradation pathways.
Topics: Anti-Bacterial Agents; Bacillus clausii; Biodegradation, Environmental; Cefotaxime; Cefpirome; Cefuroxime; Cephalosporins; Probiotics; Waste Disposal, Fluid | 2019 |
A Novel VIM-Type Metallo-β-Lactamase Variant, VIM-60, with Increased Hydrolyzing Activity against Fourth-Generation Cephalosporins in Pseudomonas aeruginosa Clinical Isolates in Japan.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cefepime; Cefpirome; Cephalosporins; Humans; Hydrolysis; Japan; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections | 2019 |
Dose Optimization of Cefpirome Based on Population Pharmacokinetics and Target Attainment during Extracorporeal Membrane Oxygenation.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteria; Cefpirome; Cephalosporins; Continuous Renal Replacement Therapy; Drug Dosage Calculations; Extracorporeal Membrane Oxygenation; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged | 2020 |
Two novel drugs as bio-functional inhibitors for copper performing excellent anticorrosion and antibacterial properties.
Topics: Adsorption; Anti-Bacterial Agents; Cefixime; Cefpirome; Cephalosporins; Copper; Corrosion; Electrons; Escherichia coli; Microbial Sensitivity Tests; Molecular Conformation; Particle Size; Staphylococcus aureus; Steel; Surface Properties | 2020 |
Separation and characterization of impurities and isomers in cefpirome sulfate by liquid chromatography/tandem mass spectrometry and a summary of the fragmentation pathways of oxime-type cephalosporins.
Topics: Cefpirome; Cephalosporins; Chromatography, High Pressure Liquid; Drug Contamination; Drug Storage; Isomerism; Oximes; Tandem Mass Spectrometry | 2021 |